Exclusions for E4_PCOS_CONSORTIUM

E4_PCOS_CONSORTIUM_EXCLUSIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Hospital discharge: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Hospital discharge: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 Cause of death: ICD-10 — E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74 Cause of death: ICD-9 — 2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940 Cause of death: ICD-8 — 2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260 2 out of 7 registries used, show all original rules.	69044
4. Check minimum number of events None	69044
5. Include endpoints None	69044
6. Filter based on genotype QC (FinnGen only)	62213

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	E4_PCOS_CONSORTIUM_EXCLUSIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
HD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
HD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E2839\|E24\|E23[0-4]\|E25\|F50\|F11\|D25\|D352\|E22\|E221\|C56\|D27\|Q96\|N643\|C74
COD_ICD_9	2563\|25631\|2568\|2550\|2580\|2434A\|2532[AB]2552\|3071A\|3072A\|3075[AB]\|304\|2180\|253X\|2531X\|2531A\|2395\|220\|7586\|2531A\|2270\|1940
COD_ICD_8	2561\|255\|258\|2561\|255\|3065\|304\|21899\|2262\|253\|253\|183\|22099\|7595\|253\|2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exclusions for E4_PCOS_CONSORTIUM based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	62213	57775	4438
Unadjusted period prevalence (%)	19.19	20.51	2.03
Median age at first event (years)	45.70	45.73	45.30

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
43384: Matched controls
270624

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

102

Kela drug reimbursment

Diabetes insipidus

122.1

321.1

253

D27.98

ICD-10 Finland

Benign tumor of the ovary (ovary), other specified histology

592.6

316.0

377

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

312.8

6037

22442

N05BA04

ATC

oxazepam; oral

1.6

310.3

11323

49744

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

308.6

8312

33898

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

16.8

307.7

401

150

8308

FHL

Hysterectomy and bilateral adnexal removal

8.3

307.7

831

639

LCA06

NOMESCO Finland

Biopsy of endometrium

2.6

307.7

7565

20468

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

13849

60788

D25

ICD-10 Finland

Leiomyoma of uterus

10.5

307.7

1132

689

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

37.8

307.7

384

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

+∞

307.7

1016

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

62.0

307.7

7649

931

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.7

307.7

6305

16175

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

307.7

3714

11188

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.2

307.7

1827

2819

C56

ICD-10 Finland

Malignant neoplasm of ovary

204.9

307.7

455

P19

ICPC

Drug abuse

8.0

307.7

804

641

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

7.9

307.7

768

613

B02AA02

ATC

tranexamic acid; systemic

2.4

307.7

8875

26231

21899

ICD-8 Finland

Uterine fibroma

+∞

307.7

3448

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.3

307.7

3765

10575

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.5

307.7

3637

9590

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

129.7

307.7

473

8305

FHL

Supravaginal amputation or resection

6.1

307.7

742

767

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

6.4

307.7

2936

3019

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

3.5

307.7

1384

2537

F50.1

ICD-10 Finland

Atypical anorexia nervosa

115.4

307.7

941

JAL30

NOMESCO Finland

Omentectomy

8.7

307.7

742

538

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

7.3

307.7

1608

1410

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.6

307.7

559

410

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

1511.6

307.7

1210

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

87.8

307.7

2409

181

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

507.3

307.7

483

N04BC06

ATC

cabergoline; oral

25.3

307.7

605

151

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

37.4

307.7

410

LCD10

NOMESCO Finland

Vaginal hysterectomy

4.1

307.7

1945

3081

N05AH04

ATC

quetiapine; oral

1.7

307.7

8111

31948

2200A

ICD-9 Finland

Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]

+∞

307.7

801

LCB14

NOMESCO Finland

Laparoscopic myolysis

31.9

307.7

1018

204

101

Kela drug reimbursment

Anterior pituitary hypofunction

122.5

307.7

1073

F50.0

ICD-10 Finland

Anorexia nervosa

225.0

307.7

1227

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

7.0

307.7

703

639

E23.2

ICD-10 Finland

Diabetes insipidus

98.0

307.7

281

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

213.2

307.7

4859

160

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.2

307.7

5799

17854

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

36.4

307.7

319

F50.2

ICD-10 Finland

Bulimia nervosa

67.2

307.7

1052

100

F50.9

ICD-10 Finland

Eating disorder, unspecified

61.6

307.7

1855

196

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

307.7

697

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

5.0

307.7

1448

1873

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

300.2

307.7

570

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

307.7

5877

19976

H01AC01

ATC

somatropin; parenteral

31.8

307.7

414

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

115.0

307.7

12941

997

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.7

307.7

2808

6807

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.9

307.7

914

650

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

+∞

307.7

4306

IFC01, ,

SPAT

69.1

307.7

286

E23.05

ICD-10 Finland

Lack of TSH

53.7

307.7

367

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

63.2

307.7

835

LCB10

NOMESCO Finland

Myomectomy

83.2

307.7

488

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

2.9

307.7

2449

5540

LCB11

NOMESCO Finland

Laparoscopic myomectomy

129.7

307.7

371

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

3.8

307.7

1365

2268

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

28.5

307.7

1296

292

Z72.2

ICD-10 Finland

Drug use

10.2

307.7

501

311

H02AB09

ATC

hydrocortisone; systemic

4.9

307.7

1619

2138

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

188.6

307.7

330

D27.92

ICD-10 Finland

Benign granulosa cell tumor in ovary (ovary)

325.0

307.7

465

N06AB03

ATC

fluoxetine; oral

2.0

307.7

5745

19440

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

5.5

307.7

1729

2015

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.0

307.7

23815

103213

128

Kela drug reimbursment

Cancers of female genital organs

5.3

307.7

1014

1212

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.1

307.7

17144

63857

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

4.4

307.7

1867

2717

E22.1

ICD-10 Finland

Hyperprolactinaemia

123.8

307.7

1253

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

16.7

307.7

467

176

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

37.7

307.7

294

G03XB02

ATC

ulipristal; oral

105.8

307.7

370

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

7.8

307.7

1982

1648

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

307.7

601

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

172.5

307.7

600

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

15.6

307.7

383

154

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

7.0

307.7

1264

1149

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

97.5

307.7

295

F50.8

ICD-10 Finland

Other eating disorders

49.7

307.7

683

LCD00

NOMESCO Finland

Hysterectomy

11.9

307.7

3880

2208

F50.3

ICD-10 Finland

Atypical bulimia nervosa

46.9

307.7

725

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

1162.8

307.7

1568

P86

ICPC

Anorexia nervosa/bulimia

16.5

307.7

413

158

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

256.9

307.7

569

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

124.2

307.7

277

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

41.3

307.7

1299

202

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

291.7

304.9

372

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

303.2

2194

5579

N06AX16

ATC

venlafaxine; oral

1.7

293.8

6761

26395

A02BC02

ATC

pantoprazole; systemic

1.5

290.4

27476

146014

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

2.9

289.9

1654

3708

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

35.2

287.1

264

N02BE01

ATC

paracetamol; systemic, rectal

1.7

285.8

37913

216661

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

276.4

20286

102254

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

17.3

272.2

308

112

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

270.7

1725

4106

N06AX11

ATC

mirtazapine; oral

1.5

270.1

14368

67977

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

4.9

268.2

712

916

LBE00

NOMESCO Finland

Salpingectomy

8.4

268.0

445

334

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

110.7

267.2

212

B01AB05

ATC

enoxaparin; parenteral

1.5

266.6

11515

52167

N05CF01

ATC

zopiclone; oral

1.5

265.9

12067

55234

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

10.9

263.7

371

214

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

263.4

9624

42016

N05BA01

ATC

diazepam; systemic, rectal

1.8

260.7

5018

18559

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

259.5

14226

67568

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

11.0

255.9

359

206

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

20.1

254.1

272

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

68.6

251.0

208

N02AX02

ATC

tramadol; systemic, rectal

1.4

249.4

15869

77384

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

18.4

247.3

273

N05AH03

ATC

olanzapine; systemic

2.1

240.1

2808

8771

N06AB04

ATC

citalopram; systemic

1.6

239.7

8467

36570

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

2.2

239.3

2362

6897

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

2.4

237.8

1865

4919

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

2.1

234.5

2672

8262

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

234.0

13001

61609

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

233.5

6222

25102

H03AA01

ATC

levothyroxine sodium; systemic

1.5

232.0

10124

45717

N03AX16

ATC

[U] pregabalin

1.5

230.3

8619

37659

E23.03

ICD-10 Finland

Lack of ACTH

429.4

227.7

274

8204

FHL

Salpingo-oophorectomy

5.8

222.8

500

544

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

221.6

904

1641

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

221.1

16452

81981

W78

ICPC

Pregnancy

0.6

216.9

3292

34951

WX402

NOMESCO Finland

General anaesthesia

1.5

216.6

8954

39889

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.1

216.0

287

149

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

1549.0

215.4

253

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.1

215.1

1046

2130

N03AE01

ATC

clonazepam; systemic

2.1

212.3

2232

6680

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

10.8

211.1

298

173

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

210.9

1867

5198

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

53.7

210.6

180

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

208.0

15931

79525

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

206.5

4064

15064

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

206.1

10091

46439

8113

FHL

Fractional scraping

2.1

205.8

2241

6799

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

205.0

10383

48088

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.8

205.0

3374

11845

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

203.8

3122

10708

LCC10

NOMESCO Finland

Supravaginal hysterectomy

11.8

201.5

271

144

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

7.0

196.3

371

331

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

12.4

194.9

256

130

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.3

194.4

1765

4966

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

193.4

2478

27728

8307

FHL

Hysterectomy and unilateral removal of adhesions

6.8

190.3

369

340

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

27.6

190.1

185

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

188.6

11222

53391

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.5

187.9

6336

26906

N06AX21

ATC

duloxetine; oral

1.6

186.0

5087

20559

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

185.5

4476

17521

C07AB07

ATC

bisoprolol; oral

1.4

185.4

15580

78527

N80.0

ICD-10 Finland

Endometriosis of uterus

2.7

184.4

1149

2697

XLA10, ,

NOMESCO Finland

2.0

183.6

2161

6748

N05AA02

ATC

levomepromazine; systemic

2.4

183.4

1464

3887

N80.1

ICD-10 Finland

Endometriosis of ovary

2.4

181.3

1406

3683

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.0

181.1

922

1930

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

1297.2

181.0

213

P18

ICPC

Medication abuse

5.7

179.4

411

457

P01AB01

ATC

metronidazole; oral, rectal

1.4

179.4

16590

84759

N05AX12

ATC

aripiprazole; systemic

2.1

178.3

1943

5889

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

6.6

178.1

354

336

JAL00

NOMESCO Finland

Biopsy of peritoneum

7.5

175.1

314

262

Z3231

NOMESCO Finland

Registered nurse

1.4

174.9

9827

46161

N06AB06

ATC

sertraline; oral

1.6

174.4

5025

20542

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

7.4

174.0

317

270

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

10.3

173.9

252

153

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

173.6

4215

16509

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

173.4

16503

84546

C08CA01

ATC

amlodipine; oral

1.4

172.3

11725

56914

N05CD07

ATC

temazepam; oral

1.7

172.3

3626

13663

J02AC01

ATC

fluconazole; systemic

1.3

172.2

18085

94012

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

171.3

2754

9576

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

56.3

169.6

144

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

2.0

169.2

2275

7451

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

16.2

168.9

196

ULC02

NOMESCO Finland

Hysteroscopy

1.9

168.8

2310

7611

AA1AD

NOMESCO Finland

CT of head and brain

1.4

167.9

9305

43548

A02BC05

ATC

esomeprazole; systemic

1.3

166.5

15396

78381

SPAT1379

SPAT

Health check-up of pregnant person

0.5

165.5

2119

23805

301

Kela drug reimbursment

Growth hormone

21.0

165.0

174

N05CF02

ATC

zolpidem; oral

1.5

163.9

6832

30263

S18

ICPC

Laceration/cut

1.3

163.8

16981

87879

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

26.5

163.8

161

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

610.5

163.6

195

E23.06

ICD-10 Finland

Empty sella

307.9

161.9

197

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

160.7

2212

7300

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

160.4

703

1339

N05BA12

ATC

alprazolam; oral

1.7

159.6

3704

14319

ZY010

NOMESCO Finland

Hospital outpatient

1.9

159.5

2300

7711

JAH01

NOMESCO Finland

Laparoscopy

2.0

159.5

1965

6234

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

159.1

5567

23752

UJF32

NOMESCO Finland

Coloscopy

1.4

158.9

8761

40900

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

157.6

1518

4374

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

52.8

157.6

135

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

47.6

157.4

137

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

1121.2

157.0

185

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

21.4

153.8

161

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

152.3

1506

4386

N03AX09

ATC

lamotrigine; oral

1.9

152.1

2212

7435

C07AA05

ATC

propranolol; systemic

1.4

151.4

8420

39316

B01AB10

ATC

tinzaparin; parenteral

1.6

151.4

3876

15357

J01AA02

ATC

doxycycline; systemic

1.3

151.0

30734

174230

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

150.7

2114

7019

SPAT1380

SPAT

Postpartum check-up

0.5

149.4

1691

19769

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

148.7

3853

15309

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

148.4

8557

40190

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

148.2

6060

51917

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

147.1

1507

4452

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

5.5

146.3

343

391

Z2221

NOMESCO Finland

Medical doctor

1.4

145.7

10395

50572

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

145.5

4432

18302

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

145.4

3216

12260

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

14.3

144.0

176

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.9

143.7

770

1661

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

142.8

166

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

142.5

3063

30067

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

142.4

2643

9586

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

+∞

142.0

165

N06AB10

ATC

escitalopram; oral

1.4

141.8

9004

42945

G02CB01

ATC

bromocriptine; systemic

2.7

138.6

850

1977

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.5

138.4

969

2413

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

56.3

137.8

117

F50

ICD-10 Finland

Eating disorders

20.3

134.3

143

W11

ICPC

Contraception oral

0.6

133.3

2092

22278

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

7.4

132.5

241

205

N03AX12

ATC

[U] gabapentin; oral

1.5

132.2

5642

25000

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

2.8

131.8

781

1783

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

+∞

131.6

153

N05AF03

ATC

chlorprothixene; systemic

2.4

131.1

1011

2638

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

130.3

12543

63628

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

66.9

128.7

107

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

+∞

128.2

149

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

128.0

4895

21205

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

167.3

127.6

160

M79.6

ICD-10 Finland

Pain in limb

1.3

127.6

17784

94757

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

126.8

3453

32210

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

126.5

1223

3527

D27

ICD-10 Finland

Benign neoplasm of ovary

14.5

126.0

153

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

4.2

124.8

398

601

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

124.4

9476

46372

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

123.5

3154

12458

SPAT1153

SPAT

Removal of sutures

1.3

123.5

10130

50121

JN4BD

NOMESCO Finland

Extensive body CT

1.7

121.5

2831

10922

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

120.5

7133

57764

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

120.4

2290

8354

F60.2

ICD-10 Finland

Dissocial personality disorder

9.1

120.4

188

129

N03AG01

ATC

valproic acid; systemic, rectal

1.8

120.3

2199

7930

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

5.8

120.1

267

288

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

119.9

2872

27594

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

27.9

119.6

116

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

891.3

119.2

141

N05BE01

ATC

buspirone; oral

2.2

118.8

1097

3102

N02AA05

ATC

oxycodone; systemic

1.5

118.8

5295

23620

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

9.8

118.6

177

113

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.5

118.0

1616

17914

Z2446

NOMESCO Finland

Social worker

1.7

117.9

2418

9011

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.1

117.6

1306

3979

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

117.6

1056

2951

Z3226

NOMESCO Finland

Physiotherapist

1.4

117.5

6215

28607

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

117.4

4449

19213

F61.0

ICD-10 Finland

Mixed personality disorders

2.6

116.6

754

1803

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

116.6

3164

12679

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

116.0

578

1194

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

115.8

5356

24049

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

151.2

114.9

145

N06AA09

ATC

amitriptyline; systemic

1.6

114.9

3176

12782

N06AB05

ATC

paroxetine; oral

1.7

114.9

2268

8360

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.7

114.5

3800

34110

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

114.2

16184

86009

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

5.5

114.2

268

306

M01AH05

ATC

etoricoxib; oral

1.3

114.0

24560

137272

SPAT1308

SPAT

Sexual health counselling

0.6

114.0

3221

29881

Y28

ICPC

Limited function/disability (Y)

8.4

114.0

188

140

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

112.7

131

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.3

112.5

975

2682

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.5

111.9

447

800

MAX99

NOMESCO Finland

Assistance to normal delivery

0.6

111.5

1824

19267

SPAT1272

SPAT

Drug screening

6.1

110.7

235

241

A04AA01

ATC

ondansetron; systemic, rectal

1.6

110.5

2919

11614

LBE10

NOMESCO Finland

Bilateral salpingectomy

13.4

110.3

139

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

+∞

110.1

128

E29.1

ICD-10 Finland

Testicular hypofunction

3.9

109.8

374

595

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

109.6

3447

14287

G02CB03

ATC

cabergoline; oral

5.0

109.6

283

355

M03BX02

ATC

tizanidine; oral

1.3

109.6

24786

139008

D39.11

ICD-10 Finland

Epithelial tumor of uncertain nature in the ovary

4.5

109.5

321

452

G47.3

ICD-10 Finland

Sleep apnoea

1.4

109.2

7082

33693

3009

Kela drug reimbursment

Niraparib

30.7

108.7

103

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

108.1

1629

5529

R2110

NOMESCO Finland

Giving the first information

1.6

107.9

2685

10524

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

107.8

804

2065

N05AX08

ATC

risperidone; systemic

1.6

107.6

2797

11082

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.1

107.5

1122

3336

J01DB01

ATC

cefalexin; oral

1.3

107.1

33920

198021

ZXE00

NOMESCO Finland

One hour or less

1.3

106.9

14280

75153

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

787.9

106.3

126

1510

Kela drug reimbursment

Niraparib

30.1

106.1

101

ZXC86

NOMESCO Finland

Use of endoscopic device

5.6

105.3

244

275

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

105.2

1427

4675

A02BC03

ATC

lansoprazole; oral

1.3

105.0

9592

48001

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

104.7

2220

8342

M01AB05

ATC

diclofenac; systemic, rectal

1.3

104.4

25219

142101

R42

ICD-10 Finland

Dizziness and giddiness

1.3

104.4

8268

40528

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

104.1

5553

25546

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

103.7

1733

6076

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.5

103.6

1407

15665

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

103.3

3543

31670

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

102.6

2982

12131

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

102.4

119

C09CA06

ATC

candesartan; oral

1.3

102.2

8565

42312

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

102.1

2334

8947

N06AX12

ATC

bupropion; oral

1.5

102.1

3176

13123

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

101.8

626

1458

J01DA01

ATC

[U] cefalexin

1.2

101.8

23717

132896

M02AA07

ATC

piroxicam; topical

1.3

101.7

11979

61958

TLC02

NOMESCO Finland

Simple extraction of IUD

1.7

101.6

1935

7054

M01AC06

ATC

meloxicam; systemic, rectal

1.3

101.4

12771

66612

JN4AD

NOMESCO Finland

Body CT examination

1.6

101.4

3113

12825

C03CA01

ATC

furosemide; systemic

1.3

101.1

8100

39746

N39.3

ICD-10 Finland

Stress incontinence

1.6

100.9

2955

12041

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

12.4

100.2

131

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

114.4

99.4

128

J01CA08

ATC

pivmecillinam; oral

1.2

99.0

19400

106474

30430

ICD-8 Finland

Drug dependence, Other hypnotics and sedatives or tranquillisers

+∞

98.9

115

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

98.8

4846

21946

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

97.9

839

2297

Z2445

NOMESCO Finland

Psychologist

1.8

97.0

1578

5485

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

96.3

14131

74956

IER01

NOMESCO Finland

Psychoeducation, group

3.4

96.0

410

768

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

3.9

94.5

322

513

L01XK02

ATC

niraparib; oral

28.4

94.3

R53

ICD-10 Finland

Malaise and fatigue

1.3

94.0

10075

51375

6171A

ICD-9 Finland

Endometriosis of ovary

3.2

93.9

438

869

R06.0

ICD-10 Finland

Dyspnoea

1.3

93.8

9253

46672

ZY000

NOMESCO Finland

Hospital inpatient

2.7

93.4

568

1315

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

14.3

93.2

114

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.6

92.5

1638

16991

N81.6

ICD-10 Finland

Rectocele

1.6

92.4

2548

10230

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

92.0

107

A06AD11

ATC

lactulose; oral

1.4

91.6

4198

18757

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

91.6

7209

35216

M01AX05

ATC

glucosamine; oral

1.4

91.5

5576

26183

N99.3

ICD-10 Finland

Prolapse of vaginal vault after hysterectomy

2.5

91.4

655

1650

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

91.3

6637

32039

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

4.2

90.6

282

418

OAA11, ,

SPAT

0.5

90.3

1083

12526

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

90.2

4609

21001

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

89.9

5031

23288

M01AH01

ATC

celecoxib; oral

1.4

89.5

5938

28254

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

89.5

1356

4608

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

89.4

104

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

89.4

9617

49007

E66.8

ICD-10 Finland

Other obesity

1.6

88.9

2316

9169

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

88.7

1389

4769

H01CC54

ATC

relugolix, estradiol and norethisterone; systemic

8.9

88.6

140

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

16.4

88.4

102

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

88.3

10868

56307

JEA00

NOMESCO Finland

Appendectomy

1.6

87.9

2065

7966

C10AA05

ATC

atorvastatin; oral

1.3

87.1

11945

62673

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

86.9

1806

6742

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

86.7

7161

35190

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

86.4

4719

21740

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

27.6

86.4

M54.5

ICD-10 Finland

Low back pain

1.2

85.4

14484

77806

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

85.3

6963

34151

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

85.2

6386

30933

H02AB02

ATC

dexamethasone; systemic

1.5

85.0

3553

15590

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

4.7

84.8

231

305

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

2.1

84.7

963

2959

6421

FHL

Appendicectomy

1.7

84.7

1630

5956

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

14.3

84.4

103

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.5

84.3

1042

11948

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

6.1

84.2

179

184

M01AE02

ATC

naproxen; oral, rectal

1.2

84.1

22585

127232

N06AA12

ATC

doxepin; systemic

1.8

84.0

1552

5603

N06AX26

ATC

vortioxetine; oral

1.5

83.9

3205

13811

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

83.8

2110

8281

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.8

83.7

1412

4961

C08CA13

ATC

lercanidipine; oral

1.4

83.7

4148

18783

J01MA02

ATC

ciprofloxacin; systemic

1.2

83.3

12634

66977

LCA10

NOMESCO Finland

Curettage of body of uterus

2.0

83.2

1013

3192

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

83.2

680

1823

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

83.0

1883

7197

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

5.6

82.9

190

212

UKC02

NOMESCO Finland

Cystoscopy

1.4

82.8

3583

15823

J01FF01

ATC

clindamycin; systemic

1.3

82.7

9266

47382

205

Kela drug reimbursment

Chronic hypertension

1.3

82.7

6424

31269

E22.80

ICD-10 Finland

Central precocious puberty

311.9

82.4

100

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

19.2

82.0

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

81.8

8098

40751

105

Kela drug reimbursment

Adrenal cortical hypofunction

6.8

81.5

157

144

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

2.8

81.5

470

1058

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

3.2

81.2

377

746

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.1

81.2

398

815

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

80.7

1846

7070

H02AB06

ATC

prednisolone; systemic

1.2

80.6

17118

93991

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

80.6

2329

9446

L17

ICPC

Foot/toe symptom/complaint

1.3

80.5

11390

59856

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

80.5

1034

3322

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

80.4

6423

31375

M01AX17

ATC

nimesulide; oral

1.3

80.3

7263

36098

M25.5

ICD-10 Finland

Pain in joint

1.2

80.2

13031

69544

L28

ICPC

Limited function/disability (L)

1.3

80.0

5947

28747

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

79.6

4262

19550

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

79.5

15976

87183

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

3.0

79.4

415

883

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

79.4

15542

84584

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.3

79.1

669

1821

C10AA07

ATC

rosuvastatin; oral

1.3

78.4

10496

54776

X78

ICPC

Fibromyoma uterus

16.9

78.1

MA3AE

NOMESCO Finland

Combined first trimester screening

0.5

78.1

1022

11534

T90

ICPC

Diabetes non-insulin dependent

1.3

77.7

6554

32244

LCB20

NOMESCO Finland

Transvaginal myomectomy

23.5

77.7

R4190

NOMESCO Finland

Nutritional therapy

1.7

77.5

1477

5379

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

3.1

77.5

379

775

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.4

77.5

629

1681

G04BD12

ATC

mirabegron; oral

1.4

77.5

3420

15150

W90

ICPC

Uncompl labour/delivery livebirth

0.5

77.2

784

9563

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

77.0

1982

7818

62699

ICD-8 Finland

Disorders of menstruation, Other

2.2

76.9

765

2231

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

76.7

3076

13375

A02BA02

ATC

ranitidine; systemic

1.3

76.7

5699

27528

C09CA01

ATC

losartan; oral

1.3

76.7

7495

37608

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

76.5

3410

15130

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

76.0

6025

29372

J01MA12

ATC

levofloxacin; systemic

1.3

76.0

5312

25421

J01EA01

ATC

trimethoprim; systemic

1.3

75.9

10421

54503

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

75.5

3225

14194

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

75.4

785

2331

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

13.7

75.4

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

75.3

29198

169682

A02BC01

ATC

omeprazole; systemic

1.3

75.3

9245

47715

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

75.3

4350

20200

N02BF02

ATC

pregabalin; oral

1.5

75.2

2401

9956

IGV01

NOMESCO Finland

Psychiatric network contact

2.6

75.2

492

1185

F34.1

ICD-10 Finland

Dysthymia

1.7

74.9

1410

5117

R52.2

ICD-10 Finland

Other chronic pain

1.8

74.9

1333

4759

WX002

NOMESCO Finland

Sedation and analgesia

1.3

74.9

5849

28448

E23.6

ICD-10 Finland

Other disorders of pituitary gland

25.7

74.6

D39.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Ovary

4.4

74.4

219

310

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

74.3

11683

62006

L13

ICPC

Hip symptom/complaint

1.3

74.2

6710

33307

N06AX05

ATC

trazodone; oral

2.0

74.0

924

2938

R4110

NOMESCO Finland

Physiotherapy

1.3

73.7

9308

48182

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

2.3

73.5

622

1694

OAA12, ,

SPAT

0.5

73.4

714

8834

J01FA06

ATC

roxithromycin; oral

1.2

73.2

14238

77246

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.0

73.1

899

2843

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

72.9

12369

66151

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

2.6

72.7

467

1114

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

72.7

4272

19885

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

15.4

72.7

X78

ICD-10 Finland

Intentional self-harm by sharp object

3.5

72.5

286

508

G03DC02

ATC

norethisterone; oral

1.4

72.0

3945

18147

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

3.1

72.0

350

713

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.5

71.9

518

1309

R60.0

ICD-10 Finland

Localized oedema

1.4

71.9

3974

18310

C10AA01

ATC

simvastatin; oral

1.2

71.8

10460

55002

N05AH02

ATC

clozapine; systemic

2.3

71.7

637

1772

1413

FHL

Laparoscopy and other therapeutic procedure

2.0

71.5

854

2673

30488

ICD-8 Finland

Drug dependence, Other

+∞

71.4

IBZ15, ,

SPAT

6.3

71.3

146

144

N06AX03

ATC

mianserin; oral

1.7

71.3

1472

5482

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

71.3

2665

11422

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

71.1

1192

4180

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

7.8

70.7

123

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

70.6

3855

17723

A10BA02

ATC

metformin; oral

1.3

70.5

7850

39986

30499

ICD-8 Finland

Drug dependence, Unspecified

+∞

70.5

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

70.5

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

69.7

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

264.8

69.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

69.6

4929

23610

N05AN01

ATC

lithium; oral

2.0

69.6

863

2738

E24.8

ICD-10 Finland

Other Cushing syndrome

518.3

69.5

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

24.3

69.5

OAA10, ,

SPAT

0.5

69.5

738

8879

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

69.5

1614

6202

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

68.8

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

68.7

4818

23043

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

68.5

1902

7638

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

68.4

5838

28718

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

2.8

68.3

401

912

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

68.3

3032

13433

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

177.8

68.2

N02BF01

ATC

gabapentin; oral

1.4

68.2

3577

16326

62620

ICD-8 Finland

Disorders of menstruation, Excessive

2.6

68.1

438

1046

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

11.1

67.8

ZXA10

NOMESCO Finland

Bilateral

1.3

67.8

5787

28465

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

13.1

67.7

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.5

67.5

481

1209

T05

ICPC

Feeding problem of adult

2.6

67.4

436

1044

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

67.0

1664

6503

R51.80

ICD-10 Finland

Headache

1.3

66.7

6376

31829

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

66.7

9777

51368

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

66.6

6372

31813

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

11.4

66.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

66.1

3492

15954

ZXA00

NOMESCO Finland

Right side

1.3

65.9

7846

40247

R06AE07

ATC

cetirizine; oral

1.2

65.8

17793

99323

N07BB01

ATC

disulfiram; oral

1.8

65.8

1167

4162

LAE20

NOMESCO Finland

Bilateral oophorectomy

6.2

65.7

137

138

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.0

65.6

758

2343

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

+∞

65.4

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

65.4

N05AB03

ATC

perphenazine; systemic, rectal

1.8

65.2

1097

3850

IBZ14, ,

SPAT

6.3

65.1

133

131

IBZ04, ,

SPAT

34.1

64.8

F50.5

ICD-10 Finland

Vomiting associated with other psychological disturbances

88.5

64.7

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

64.5

6655

33536

G03DB01

ATC

dydrogesterone; oral

1.3

64.4

5418

26579

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

0.5

64.1

625

7734

IEV99

NOMESCO Finland

Other psychiatric network intervention

3.2

64.0

296

585

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

17.3

63.9

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

63.7

1674

6631

8202

FHL

Oophorectomy

5.4

63.6

151

175

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

63.6

37581

225699

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

63.5

6719

33956

R18

ICD-10 Finland

Ascites

2.4

63.5

514

1373

R03AC02

ATC

salbutamol; inhalant

1.2

63.5

21855

124516

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

63.2

14010

76679

ZXY60

NOMESCO Finland

2-person team, nurses

3.3

62.8

270

509

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

5.1

62.8

158

194

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

6.3

62.8

130

8351

FHL

Removal of pelvic floor brackets

4.3

62.8

192

281

L15

ICPC

Knee symptom/complaint

1.2

62.5

9205

48330

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

17.5

62.3

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

4.5

62.3

180

251

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

62.3

4039

19069

N30.0

ICD-10 Finland

Acute cystitis

1.3

62.2

7199

36769

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.3

62.1

508

1363

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

62.0

2994

13458

LAE10

NOMESCO Finland

Unilateral oophorectomy

4.6

62.0

175

239

HA1AA

NOMESCO Finland

X-ray mammography

1.4

62.0

3008

13535

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

62.0

3623

16826

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

61.9

4625

22299

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

61.9

N06AG02

ATC

moclobemide; oral

1.7

61.9

1290

4816

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

2.6

61.8

407

984

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

61.7

949

3239

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

61.3

3359

15431

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.4

61.2

2796

12445

R4110, ,

SPAT

1.3

61.1

4429

21259

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

61.1

1670

6679

IFC99

NOMESCO Finland

Other biological psychiatric intervention

7.3

60.9

111

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

14.4

60.9

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

60.9

8159

42371

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

2.4

60.8

461

1195

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

60.4

910

3086

E34.35

ICD-10 Finland

Abnormal growth retardation

4.5

60.3

175

245

M01AH02

ATC

rofecoxib; oral

1.4

60.3

3624

16902

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.8

60.2

961

3318

G04BD08

ATC

solifenacin; oral

1.6

60.2

1779

7244

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

59.8

998

3494

SPAT1196

SPAT

Monitoring of normal pregnancy

0.6

59.8

1232

12364

SPAT1315

SPAT

Periodic health check-up of children and adolescents

0.6

59.7

1553

14790

Z71.8

ICD-10 Finland

Other specified counselling

1.2

59.4

13654

74866

OAB43, ,

SPAT

0.8

59.2

11208

80306

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.1

59.2

654

1989

WVA30, ,

SPAT

1.5

59.1

1995

8362

A01

ICPC

Pain general/multiple sites

1.4

58.8

3540

16510

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

58.6

3883

18381

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.1

58.4

659

2020

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

58.2

2888

13039

B17.1

ICD-10 Finland

Acute hepatitis C

7.7

58.2

102

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.1

58.2

590

1735

N06AX22

ATC

agomelatine; oral

1.8

58.1

931

3219

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

57.9

7069

36300

J02AC02

ATC

itraconazole; systemic

1.3

57.7

5979

30099

M02AA10

ATC

ketoprofen; topical

1.3

57.7

5093

25115

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

9.8

57.7

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

57.5

7079

36379

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

57.3

21372

122117

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

57.3

8271

43268

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.8

57.1

332

752

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

14.1

57.0

R11

ICD-10 Finland

Nausea and vomiting

1.4

57.0

3247

15005

SPAT1227

SPAT

Substance abuse rehabilitation

3.4

57.0

233

425

C05AA08

ATC

fluocortolone; rectal, topical

1.3

56.9

4119

19754

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

56.9

3990

19046

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

56.9

2983

13596

104

Kela drug reimbursment

Thyroid insufficiency

1.4

56.7

2415

10604

X84

ICD-10 Finland

Intentional self-harm by unspecified means

4.4

56.3

165

233

N05BA02

ATC

chlordiazepoxide; systemic

2.1

56.2

571

1680

XCK00

NOMESCO Finland

Perimetry

1.5

56.2

1784

7380

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

9.0

56.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

56.1

13564

74615

C07AB02

ATC

metoprolol; systemic

1.3

56.1

5269

26191

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.5

56.1

393

981

T99

ICPC

Endocr/metab/nutrit disease other

2.2

56.0

528

1507

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.5

56.0

702

8035

L03

ICPC

Low back symptom/complaint

1.2

56.0

11294

61095

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

56.0

4361

21135

30650

ICD-8 Finland

Special symptoms not elsewhere classified, Feeding disturbance

+∞

55.9

A46

ICD-10 Finland

Erysipelas

1.3

55.8

3962

18945

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.7

55.8

2543

21795

D72

ICPC

Viral hepatitis

7.4

55.7

100

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.0

55.5

715

2300

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

1.9

55.5

770

2541

N06AA06

ATC

trimipramine; systemic

2.0

55.5

713

2292

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

5.1

55.4

138

168

1350

FHL

Hysteroscopy

2.8

55.3

323

733

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

211.4

55.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

55.2

4376

21257

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

55.2

1843

7707

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

55.1

5959

30140

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

55.0

6984

35995

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

0.5

55.0

578

6984

P76

ICPC

Depressive disorder

1.4

54.9

2767

12524

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

54.9

4891

24137

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

54.8

2310

10121

PD2DT

NOMESCO Finland

Embolisation of gynekological tumor

76.0

54.7

SPAT1216

SPAT

Assessment of functional ability

1.3

54.6

4333

21047

C03AA03

ATC

hydrochlorothiazide; oral

1.5

54.6

2264

9889

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

54.6

11325

61392

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

4.7

54.0

148

197

SPAT1265

SPAT

Breathalyser

2.9

54.0

294

642

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

53.9

8104

42533

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

53.9

553

1634

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

53.6

1543

6243

S29

ICPC

Skin symptom/complaint other

1.2

53.6

7105

36787

SFA30

NOMESCO Finland

Three-surface restoration

1.2

53.5

15046

83776

JAH00

NOMESCO Finland

Laparotomy

1.9

53.5

724

2370

IEY01

NOMESCO Finland

Psychoeducation, individual

2.6

53.4

361

885

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.8

53.4

296

653

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

53.3

3853

18465

E23.0

ICD-10 Finland

Hypopituitarism

399.2

53.3

N05AD01

ATC

haloperidol; systemic

1.8

53.2

815

2778

R50.9

ICD-10 Finland

Fever, unspecified

1.3

53.1

4973

24696

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

53.0

3491

16498

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.5

53.0

210

375

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

53.0

2785

12695

IBZ99

NOMESCO Finland

Other behavioural observation

31.2

52.9

N81.5

ICD-10 Finland

Vaginal enterocele

2.1

52.9

572

1726

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

15.5

52.6

X77

ICPC

Malignant neopl genital female other

5.0

52.5

134

167

ZXA05

NOMESCO Finland

Left side

1.2

52.4

7176

37277

R52.9

ICD-10 Finland

Pain, unspecified

1.3

52.4

3658

17441

E25.9

ICD-10 Finland

Adrenogenital disorder, unspecified

137.4

52.2

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

51.9

1205

4628

W12

ICPC

Contraception intrauterine

0.7

51.9

2763

23114

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

104.6

51.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

51.8

3388

15992

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

51.6

4393

21535

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

51.6

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

4.9

51.6

134

170

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

51.5

3443

16308

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

51.4

1172

4480

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.0

51.4

266

564

S10

ICPC

Boil/carbuncle

1.5

51.2

1865

7940

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.6

51.1

198

348

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.1

51.1

520

1532

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

51.1

10385

56119

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

51.0

1475

5975

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

50.9

15491

86710

6170A

ICD-9 Finland

Endometriosis of uterus

2.7

50.9

308

713

G01AF01

ATC

metronidazole; vaginal

1.3

50.9

3470

16481

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

50.9

3664

17543

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.1

50.8

533

1589

K85

ICPC

Elevated blood pressure

1.3

50.8

4892

24367

D35.30

ICD-10 Finland

Craniopharyngoma

83.7

50.8

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

2.7

50.7

298

679

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

380.4

50.7

A03FA02

ATC

cisapride; oral, rectal

1.4

50.6

2152

9443

P29

ICPC

Psychological sympt/compl other

1.4

50.5

3168

14855

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

50.4

611

1924

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.3

50.4

4402

21650

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

50.2

3181

14941

E23.08

ICD-10 Finland

Hypopituitarism

192.5

50.1

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

192.5

50.1

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.5

50.1

200

359

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.6

50.1

1086

10781

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

50.1

1856

7928

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

49.9

1231

4800

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

49.9

9257

49567

D01

ICPC

Abdominal pain/cramps general

1.3

49.9

4864

24264

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

49.7

1226

4780

R4140

NOMESCO Finland

Psychotherapy

2.9

49.6

263

566

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

49.5

1015

3772

WZC30

NOMESCO Finland

Teaching

1.3

49.5

4906

24522

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

49.4

8722

46469

M48.0

ICD-10 Finland

Spinal stenosis

1.4

49.4

3153

14823

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

49.4

2107

9249

8460/3-C56.9

ICD-O-3

Low grade serous carcinoma of ovary

100.0

49.4

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.5

49.2

340

843

ZXY49

NOMESCO Finland

Other health care provider

3.2

49.1

221

430

P99

ICPC

Psychological disorders other

1.6

49.0

1164

4497

A28

ICPC

Limited function/disability NOS

1.3

48.9

4724

23532

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.6

48.8

1163

4497

G01AF05

ATC

econazole; vaginal

1.4

48.6

2926

13631

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

3.3

48.4

214

412

P74

ICPC

Anxiety disorder/anxiety state

1.5

48.3

1899

8208

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

48.2

10417

56545

L08

ICPC

Shoulder symptom/complaint

1.2

48.2

7783

41087

G02CB04

ATC

quinagolide; oral

14.2

48.2

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

5.8

48.2

107

116

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

25.0

48.0

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

48.0

2376

10715

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

47.9

999

3730

K59.0

ICD-10 Finland

Constipation

1.5

47.9

1712

7259

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

47.9

3333

15873

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

47.8

5786

29607

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

47.8

2817

13077

U02

ICPC

Urinary frequency/urgency

1.3

47.7

5625

28700

J05AB01

ATC

aciclovir; systemic

1.2

47.6

7896

41787

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

47.6

2733

12635

62532

ICD-8 Finland

Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina

2.4

47.5

352

903

SPAT1240

SPAT

Therapeutic discussion

1.3

47.5

4122

20243

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

47.5

2178

9687

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.5

47.2

332

831

R02

ICPC

Shortness of breath/dyspnoea

1.3

47.1

4454

22119

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

46.9

2693

12449

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

46.7

4635

23156

OAB39, ,

SPAT

0.7

46.7

1306

12268

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

77.5

46.6

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

46.6

7392

38937

M79.7

ICD-10 Finland

Fibromyalgia

1.5

46.4

1380

5625

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

122.8

46.3

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

46.1

4785

24035

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

46.1

10239

55678

C03DA01

ATC

spironolactone; oral

1.3

45.9

3186

15162

N06AB08

ATC

fluvoxamine; oral

1.8

45.9

775

2724

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

4.7

45.8

125

166

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

1.8

45.8

713

2444

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

3.1

45.7

217

437

L03AA13

ATC

pegfilgrastim; parenteral

1.6

45.7

1348

5484

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

45.7

1993

8784

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

45.7

1736

7452

F11.00

ICD-10 Finland

Intoxication caused by opiates uncomplicated

342.8

45.6

D06

ICPC

Abdominal pain localized other

1.3

45.6

3411

16410

1410

FHL

Laparoscopy

1.7

45.5

890

3266

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.2

45.4

431

1235

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

45.4

2908

13673

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

45.3

6518

33971

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.6

45.3

1220

4860

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

5.8

45.2

100

108

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

45.1

670

2263

E0000UV, ,

ATC

1.2

44.9

15977

90269

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

44.9

2175

9769

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

1.7

44.8

904

3345

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.7

44.8

1256

11794

W85

ICPC

Gestational diabetes

0.6

44.8

731

7781

F11.09

ICD-10 Finland

Intoxication caused by opiates UNS

336.6

44.8

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

336.6

44.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

44.7

2904

13682

IBZ03

NOMESCO Finland

Addiction psychiatry evaluation

13.5

44.7

R35

ICD-10 Finland

Polyuria

1.5

44.6

1586

6718

N04BC05

ATC

pramipexole; oral

1.4

44.5

2150

9650

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

44.4

4510

22589

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

44.3

3708

18115

IBZ12

NOMESCO Finland

Psychiatric evaluation of substance intoxication

23.4

44.2

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.7

44.1

886

3275

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.8

44.1

693

2383

Z37.0

ICD-10 Finland

Single live birth

0.7

44.1

2163

18354

WX320

NOMESCO Finland

Spinalanesthesy

1.2

44.1

7709

40970

G44.2

ICD-10 Finland

Tension-type headache

1.3

44.0

5330

27253

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

62.5

44.0

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

0.7

44.0

1209

11401

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

44.0

3913

19270

C09AA02

ATC

enalapril; systemic

1.3

43.9

4618

23226

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

43.8

2619

12180

G04BD07

ATC

tolterodine; oral

1.6

43.7

1282

5209

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

43.7

7401

39209

MAE00

NOMESCO Finland

Outlet vacuum delivery

0.6

43.3

889

8942

6200A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Follicular cyst of ovary

3.0

43.3

217

452

AA400

NOMESCO Finland

Electroconvulsive therapy

2.6

43.2

289

706

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.2

43.2

396

1119

ZXD20

NOMESCO Finland

Day surgery

1.3

43.1

4013

19878

J01MA06

ATC

norfloxacin; oral

1.3

43.1

4302

21497

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

43.0

882

3279

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

42.9

1593

6806

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

4.8

42.9

114

148

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.2

42.8

8330

44704

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

42.7

4411

22135

M79.1

ICD-10 Finland

Myalgia

1.2

42.6

5582

28786

N83.0

ICD-10 Finland

Follicular cyst of ovary

1.9

42.5

552

1783

T40.2

ICD-10 Finland

Poisoning: Other opioids

8.9

42.5

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

42.5

1668

7206

OAA80, ,

SPAT

0.7

42.4

2062

17529

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.6

42.4

1076

4227

R01AD08

ATC

fluticasone; nasal

1.2

42.3

10461

57331

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

42.3

745

2653

N83.1

ICD-10 Finland

Corpus luteum cyst

2.0

42.2

508

1597

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.4

42.2

327

858

R63.0

ICD-10 Finland

Anorexia

3.4

42.0

173

318

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

41.9

1529

6509

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

41.8

1948

8686

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

41.8

3399

16535

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4281824) Cell count and differential, peritoneal fluid

1227

2127

3.67

321.73

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1533

3171

3.09

308.25

3.1

1.7

168.42

184.42

pmol/l

4.76

1474

3017

(43055514) Macroprolactin [Presence] in Serum or Plasma

656

541

7.66

307.65

1.6

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

808

784

6.53

307.65

1.7

1.2

74.06

72.61

1.51

772

745

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

2830

5677

3.26

307.65

1.5

1.4

158.92

96.90

pmol/l

5.29

2767

5518

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

799

765

6.62

307.65

1.7

1.2

964.15

371.04

mu/l

3.63

763

726

(3024561) Albumin [Mass/volume] in Serum or Plasma

20535

99238

1.55

307.65

4.9

4.8

36.24

36.31

g/l

1.05

19265

93121

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

22881

110944

1.61

307.65

7.4

6.6

1.22

mmol/l

1.34

19835

96287

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

35308

195769

1.67

307.65

5.7

4.7

14.64

14.58

pmol/l

5.25

33027

182667

(3019550) Sodium [Moles/volume] in Serum or Plasma

40117

231285

2.09

307.65

19.7

15.1

139.63

139.64

mmol/l

0.33

39512

226599

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

909

460

12.57

307.65

3.3

1.7

1.10

1.38

ug/l

1.66

857

443

(3021387) Prolactin [Units/volume] in Serum or Plasma

4151

11584

2.37

307.65

2.9

1.3

370.59

288.27

mu/l

15.41

3865

10343

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

463

220

13.26

307.65

2.0

1.2

1.24

1.06

nmol/l

0.33

(3023103) Potassium [Moles/volume] in Serum or Plasma

40156

231716

2.09

307.65

19.9

15.3

3.92

3.93

mmol/l

12.42

39496

226566

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

5665

14149

2.72

307.65

4.8

2.4

62.17

43.82

u/ml

2.11

5513

13646

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

32731

174876

1.68

307.65

8.7

7.7

77.83

77.34

u/l

1.10

31135

166481

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23544

118068

1.53

307.65

6.6

6.0

10.23

10.64

umol/l

5.30

22322

112062

(3009214) Lutropin [Units/volume] in Serum or Plasma

3297

8033

2.69

307.65

1.9

1.3

9.09

11.13

u/l

11.58

2605

6482

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2117

1164

11.88

307.65

3.2

1.6

19.48

20.80

nmol/l

3.33

2048

1096

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7290

22977

2.18

307.65

3.2

2.0

366.08

382.59

nmol/l

8.02

6827

21326

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

20591

98493

1.58

307.65

6.9

6.1

1.22

mmol/l

2.97

19108

91605

(3015377) Calcium [Moles/volume] in Serum or Plasma

16580

79601

1.48

297.68

3.5

3.3

2.36

mmol/l

2.51

15131

73075

(3013826) Glucose [Moles/volume] in Serum or Plasma

25045

131445

1.45

273.92

5.3

4.6

6.47

6.49

mmol/l

0.71

23811

122344

(3018418) pH of Serum or Plasma

14200

66992

1.48

271.00

4.4

4.0

7.40

0.17

10060

47312

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

38708

223170

1.76

269.27

6.9

5.6

1.80

1.83

mu/l

3.66

36468

210801

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

450

377

7.51

250.11

3.5

1.5

93.35

113.31

ng/l

0.79

260

211

(3044640) Blood type and Crossmatch panel - Blood

15526

75399

1.44

249.50

2.5

2.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

38061

219303

1.67

247.63

16.3

12.8

84.90

86.04

ml/min/173m2

21.44

35367

199921

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

31778

175996

1.47

246.30

4.7

4.3

11.39

11.22

mm/h

1.47

29943

166159

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

21936

113632

1.41

244.80

2.8

2.5

4153.27

76.63

nmol/l

0.50

20115

105279

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8250

35349

1.56

242.25

3.7

3.4

0.82

mmol/l

0.64

7756

33238

(3032080) INR in Blood by Coagulation assay

18533

93299

1.42

242.13

12.2

11.5

1.17

1.18

inr

2.00

15295

77349

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1875

4927

2.44

241.05

3.0

1.6

38.60

43.55

nmol/l

8.13

1819

4850

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

19284

97948

1.41

238.09

2.2

2.0

99.12

98.15

pmol/l

1.80

9879

51400

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

14980

73013

1.43

230.95

2.9

2.6

58.74

69.02

u/l

0.65

13800

67910

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5185

20117

1.69

225.16

2.5

2.3

0.22

g/l

0.94

4853

18819

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

21416

111436

1.39

224.45

2.8

2.7

—

estimate

—

(3044889) 12 lead EKG panel

28300

154466

1.41

223.42

4.0

3.6

0.35

3131.92

0.93

268

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

37778

218324

1.61

222.89

5.3

4.5

5.81

5.75

mmol/l

14.49

35098

204200

(3013650) Neutrophils [#/volume] in Blood by Automated count

25598

137402

1.40

221.88

10.9

9.2

4.01

e9/l

0.02

22295

119860

(3023323) Follitropin [Units/volume] in Serum or Plasma

4973

19155

1.70

221.52

1.6

1.3

23.57

26.60

iu/l

8.54

4214

16484

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6560

27192

1.59

219.28

5.8

1.05

mmol/l

0.37

6091

25186

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1456

3603

2.57

211.29

2.5

1.4

435.14

361.39

mu/l

2.59

1247

2858

(3013512) EKG study

14127

68983

1.41

210.17

3.6

3.2

0.68

0.74

0.25

157

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3186

10904

1.89

209.54

5.1

2.0

10.31

11.25

nmol/l

7.48

2933

9921

(3031040) Bacteria [#/volume] in Urine by Automated count

28764

158322

1.40

206.55

5.2

4.6

1516.17

2366.34

e6/l

2.01

352

1956

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

36722

211923

1.53

199.18

6.4

5.5

38.52

38.13

mmol/mol

14.46

34487

200804

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13457

65835

1.40

194.08

2.4

2.1

197.28

181.34

u/l

0.50

12751

62350

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11780

56405

1.42

191.68

2.4

2.2

—

(3007463) Buprenorphine [Presence] in Urine

180

30.47

189.57

9.2

2.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15862

80122

1.37

186.56

3.7

3.2

33.01

31.68

u/l

0.61

15003

75971

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

770

1429

3.40

182.67

2.1

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

41216

245787

1.92

181.95

21.8

16.9

70.33

70.90

umol/l

4.05

40828

243097

(3013115) Eosinophils [#/volume] in Blood

23619

127198

1.35

181.54

7.2

6.6

0.18

0.19

e9/l

2.00

20741

112476

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1850

5464

2.16

181.25

1.7

1.4

0.34

0.45

nmol/l

5.80

1404

4330

(3001604) Monocytes [#/volume] in Blood

22933

123002

1.35

180.67

6.8

6.4

0.55

e9/l

1.69

19818

107136

(3006315) Basophils [#/volume] in Blood

22973

123257

1.35

180.52

6.8

6.4

0.04

e9/l

0.73

19832

107283

(3021960) Folate [Moles/volume] in Serum or Plasma

12652

61892

1.39

179.07

1.8

1.6

20.59

20.56

nmol/l

0.09

10828

53676

(3033658) Prothrombin time (PT) actual/Normal

11785

56970

1.40

178.89

4.3

3.9

94.97

93.59

7.77

11478

55581

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12586

61608

1.39

176.98

2.5

2.3

2.84

2.71

mg/l

8.03

10896

53663

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

15549

78853

1.36

174.98

3.7

3.3

33.34

58.69

ng/l

1.96

9679

46289

(3019198) Lymphocytes [#/volume] in Blood

23368

126070

1.34

173.92

6.8

6.4

1.97

1.95

e9/l

0.73

20663

112317

(3019069) Monocytes/Leukocytes in Blood

21189

112905

1.33

169.72

7.1

6.6

8.44

8.51

3.06

19861

106592

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

642

1112

3.64

168.13

2.0

1.4

2112031.49

1936090.83

iu/ml

0.10

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

263

181

9.11

167.97

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

15490

78987

1.35

165.42

3.5

3.3

1.50

2.20

e6/l

—

(3023368) Bacteria identified in Blood by Culture

11331

55025

1.39

164.51

4.7

4.0

—

(3006504) Eosinophils/Leukocytes in Blood

21106

112701

1.33

164.37

7.0

6.5

2.77

2.81

2.06

19756

106308

(3022096) Basophils/Leukocytes in Blood

21095

112656

1.33

163.98

7.1

6.6

0.69

0.70

19714

106066

(3009508) Creatinine [Moles/volume] in Urine

14317

72207

1.35

163.87

4.3

3.3

7.02

7.33

mmol/l

11.97

12093

62465

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4775

19653

1.58

160.08

3.4

4.2

18.11

23.63

ug/l

0.71

3623

15450

(3037467) Urinalysis macro (dipstick) panel - Urine

29338

164631

1.34

159.99

5.1

4.5

2.93

62.22

0.51

230

(3002256) Pathology report gross observation

6804

30257

1.48

159.57

1.3

—

(3002030) Lymphocytes/Leukocytes in Blood

21624

116351

1.32

156.11

6.9

6.5

28.99

29.05

0.33

20470

110929

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2083

23127

0.54

155.59

1.5

1.6

1044.93

1012.22

mu/l

0.54

1717

19539

(3042517) Benzodiazepines panel - Urine

293

265

6.94

153.43

4.6

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

7467

34055

1.44

152.95

1.8

1.7

1176.73

1177.42

nmol/l

0.02

5658

26302

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4439

18187

1.58

151.13

3.5

4.45

4.55

pmol/l

9.34

4027

16433

(3018010) Neutrophils/Leukocytes in Blood

21247

114341

1.31

151.05

6.8

6.3

56.61

56.53

0.40

20246

109760

(3022948) Iron [Moles/volume] in Serum or Plasma

8218

38231

1.42

150.81

2.5

13.34

13.54

umol/l

1.53

7645

35766

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11335

55692

1.36

150.30

3.0

1064.44

1181.04

ng/l

1.98

9473

47082

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

39539

234585

1.58

146.70

17.2

13.8

21.52

mg/l

0.02

33116

190012

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

40919

245132

1.73

141.27

13.5

11.0

25.79

24.93

u/l

5.83

39933

239090

(4035726) Immunohistochemistry procedure

4393

18364

1.55

136.13

1.4

—

(3021589) Normoblasts [#/volume] in Blood

19916

107188

1.29

135.13

12.4

10.4

0.00

e9/l

0.60

16297

87356

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7563

35259

1.41

135.11

2.5

2.43

2.41

g/l

2.64

6937

32614

(4198724) Urine methamphetamine measurement

603

1169

3.25

133.90

3.4

2.0

—

(3002582) Erythrocytes [#/volume] in Urine

14027

72165

1.31

132.32

3.5

3.2

91.63

59.21

e6/l

1.33

10599

53892

(3030467) Casts [#/volume] in Urine by Automated count

12317

62387

1.32

129.00

3.4

3.1

0.37

0.38

e6/l

0.27

8937

44670

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6920

31993

1.42

128.88

2.6

2.5

22.03

22.66

3.23

6400

29788

(3026782) Osmolality of Urine

8631

41596

1.37

125.07

3.1

2.8

502.43

517.02

mosm/kgh2o

6.35

7565

36256

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

38647

229386

1.47

122.60

5.8

5.1

2.80

mmol/l

0.40

36138

217108

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4654

20162

1.49

121.18

3.6

3.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9097

44404

1.35

120.87

2.7

2.8

2.45

2.44

mmol/l

4.92

8176

39713

(3018095) Leukocytes [#/volume] in Urine

16359

86656

1.29

120.52

4.3

3.8

96.70

93.13

e6/l

0.17

11294

58035

(3009261) Glucose [Presence] in Urine by Test strip

23782

132090

1.27

118.65

4.3

3.8

0.41

0.14

estimate

0.44

5051

26026

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

36345

213617

1.38

118.55

4.4

3.9

1.31

1.24

mmol/l

66.63

33576

200656

(3008295) Osmolality of Serum or Plasma

857

2189

2.47

116.21

2.2

1.4

282.64

277.82

mosm/kgh2o

7.26

698

1630

(36304419) Bacteria [Presence] in Urine

11793

60106

1.31

115.12

3.3

3.0

16.04

112.61

estimate

0.85

240

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

38190

226988

1.41

107.96

5.2

4.6

4.78

4.76

mmol/l

5.63

35867

215594

(3021601) Nitrite [Presence] in Urine by Test strip

23270

129751

1.26

106.69

4.3

3.8

0.00

estimate

0.06

5076

26469

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9262

46072

1.32

105.97

1.7

31396999.80

37600442.41

pmol/l

0.46

7762

39125

(3035350) Ketones [Presence] in Urine by Test strip

23503

131299

1.25

105.35

4.3

3.8

4.59

3.56

estimate

0.42

5254

26976

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10711

54412

1.30

105.11

1.8

1.03

1.10

mg/l

1.66

8181

41674

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2531

9854

1.64

104.35

1.9

1.7

0.25

0.30

mg/l

3.52

1091

4354

(3001122) Ferritin [Mass/volume] in Serum or Plasma

23251

129804

1.25

104.35

3.6

3.2

92.13

91.72

ug/l

0.11

21812

122919

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

37980

225780

1.40

103.62

5.2

4.5

1.52

mmol/l

0.08

35447

213555

(3020682) Albumin/Creatinine [Ratio] in Urine

12343

64090

1.28

101.61

4.1

8.69

8.70

mg/mmol

0.00

7157

38523

(3050129) First trimester maternal screen panel - Serum or Plasma

1361

15190

0.54

101.00

1.4

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

28893

165765

1.26

99.84

3.8

3.1

42.82

40.17

u/l

5.60

27335

157696

(3012516) Albumin [Mass/volume] in Urine

12167

63184

1.28

99.60

3.5

43.27

46.61

mg/l

0.75

7194

38516

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3920

17046

1.48

98.93

3.8

3.7

83.42

81.55

ng/l

0.52

3371

14963

(3003396) Base excess in Arterial blood by calculation

4812

21827

1.42

97.11

7.6

7.5

0.90

0.97

mmol/l

0.58

4021

17914

(3019977) pH of Arterial blood

4849

22047

1.42

96.53

7.7

7.6

7.42

2.19

2621

11889

(3015736) pH of Urine

19139

105095

1.24

96.07

4.0

3.4

6.26

6.25

0.82

10703

58698

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4832

21983

1.42

95.81

7.7

7.5

5.14

5.08

kpa

4.33

4668

21124

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1512

5208

1.84

95.69

1.5

1.3

22.89

26.82

u/l

4.77

1264

4234

(3027801) Oxygen [Partial pressure] in Arterial blood

4830

21977

1.42

95.69

7.7

7.5

12.99

12.86

kpa

0.84

4660

21120

(3019225) pH of Specimen

4368

19514

1.44

95.67

4.1

3.9

7.37

7.35

2.87

3138

13804

(40768797) Stomach Pathology biopsy report

6635

31827

1.35

95.64

1.2

—

(3042936) Bacteria identified in Isolate by Culture

6343

30279

1.36

94.17

2.1

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7103

34558

1.34

92.92

2.0

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

517

1147

2.83

91.91

2.2

1.4

5.47

9.63

nmol/l

0.37

435

926

(3000850) Epithelial cells [#/volume] in Urine

9655

49087

1.29

91.81

2.9

2.6

7.48

7.29

e6/l

0.28

8767

44394

(3019832) Treponema pallidum Ab [Presence] in Serum

4921

40476

0.73

87.06

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

4023

18028

1.43

86.10

7.8

7.5

1.27

1.31

mmol/l

1.51

3954

17700

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

17552

96261

1.23

85.27

2.0

1.9

1.41

1.33

mmol/l

28.10

14748

82963

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3231

13909

1.49

85.09

8.3

24.98

24.80

mmol/l

2.09

3210

13812

(40758558) Short blood count panel - Blood

13467

71824

1.25

84.49

7.0

6.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

4826

22440

1.38

83.43

2.7

1.78

0.17

4260

20105

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

975

11258

0.53

80.60

1.5

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

684

1874

2.30

79.69

3.8

1.6

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5209

24705

1.36

79.32

4.9

4.4

32.60

32.71

0.28

3595

17299

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3753

16878

1.42

78.36

4.1

3.6

1.23

mmol/l

0.21

3241

14543

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6181

30156

1.32

77.76

2.1

1.7

1.44

1.38

11.66

5512

26990

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4786

22473

1.37

77.49

2.6

2.5

37.21

41.32

u/l

0.78

4064

19044

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1192

12834

0.57

76.98

1.5

62.46

62.52

ug/l

0.01

971

10675

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3011

13096

1.47

74.93

3.9

5.18

5.14

kpa

2.03

2869

12503

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

835

2550

2.06

74.65

1.3

1.2

30.75

35.43

nmol/l

0.26

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1121

12140

0.56

73.88

1.4

1.5

1.14

1.17

ratio

0.47

637

7252

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1126

12176

0.57

73.80

1.4

1.5

1.18

1.19

ratio

0.09

646

7353

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1126

12175

0.57

73.78

1.4

1.5

0.95

ratio

0.01

641

7288

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7099

35537

1.29

73.56

3.1

2.9

4.36

4.20

e6/l

0.35

3320

16506

(3009343) pH of Capillary blood

2933

12749

1.47

73.15

3.9

7.41

7.42

0.31

2430

10567

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3986

18326

1.39

73.08

8.4

8.3

120.45

120.33

g/l

0.14

3901

17894

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

12406

66394

1.23

72.58

1.4

1.28

1.59

u/ml

2.39

3400

18763

(3011985) Renin [Units/volume] in Plasma

998

3295

1.91

71.78

2.1

1.6

55.28

63.04

mu/l

0.65

908

2978

(3016502) Oxygen saturation in Arterial blood

4172

19395

1.38

71.46

8.1

7.9

95.81

95.84

0.09

4047

18680

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1114

11952

0.57

70.83

1.4

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5558

27076

1.32

69.94

2.7

6.64

7.52

umol/l

2.71

4706

23227

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7664

38962

1.28

69.89

3.0

2.8

1.26

1.23

e6/l

0.10

3898

19980

(3000991) Gas panel - Venous blood

3862

17798

1.39

69.62

9.3

8.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4766

22729

1.35

69.28

4.1

4.2

237.01

239.69

u/l

0.61

4502

21614

(3007164) IgA [Mass/volume] in Serum or Plasma

10650

56353

1.24

68.41

1.5

2.17

2.23

g/l

2.74

6542

35555

(3023520) Reticulocytes [#/volume] in Blood

3643

16785

1.39

65.56

2.5

2.6

71.74

70.21

e9/l

1.52

2588

12117

(3022145) Colonoscopy Study observation

5359

26196

1.32

65.43

1.3

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

12963

70257

1.22

65.29

4.5

4.0

0.00

estimate

0.19

4881

25058

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

535

1449

2.32

64.05

24.2

19.6

1374.65

3648.87

nmol/l

1.05

517

1392

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5186

25321

1.32

63.70

1.9

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2581

11233

1.46

63.67

3.8

1.90

1.68

mmol/l

2.33

1929

8141

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

512

1372

2.34

62.78

18.8

14.5

799.23

2486.45

nmol/l

0.81

504

1328

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

9650

50949

1.23

62.13

1.4

1.3

29.90

31.21

iu/ml

0.14

2915

15506

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6266

31473

1.28

62.04

2.3

2.2

29.33

29.26

0.38

6096

30574

(3020779) Urea [Moles/volume] in Serum or Plasma

3642

16941

1.37

61.66

7.7

7.5

8.54

8.79

mmol/l

1.18

3470

16229

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

955

3270

1.84

61.47

1.6

1.3

0.77

1.86

nmol/l

0.89

921

3160

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

966

3320

1.83

61.45

1.6

1.3

0.34

0.18

nmol/l

1.04

186

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4306

20573

1.34

61.32

4.9

4.0

5.88

5.83

kpa

3.14

4199

20065

(3007853) Bacteria identified in Skin by Aerobe culture

5558

27534

1.30

61.14

1.9

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

3689

17258

1.36

60.19

4.3

3.6

4.56

4.58

kpa

0.33

3589

16810

(3024666) Lithium [Moles/volume] in Serum or Plasma

550

1563

2.21

58.95

13.1

0.61

0.62

mmol/l

0.50

509

1448

(3012544) pH of Venous blood

4319

20772

1.33

58.64

4.9

4.0

7.38

0.98

2483

11713

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4847

23697

1.31

58.59

6.7

6.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

841

2807

1.89

58.58

1.6

1.2

0.27

0.18

nmol/l

1.21

602

2135

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

756

8568

0.54

58.30

1.5

60.76

60.27

ug/l

0.11

756

8568

(3047352) Trisomy 18 risk [Likelihood] in Fetus

940

10016

0.58

57.97

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

375

900

2.61

57.81

2.0

1.2

425.33

103.24

nmol/24h

1.80

375

900

(3010421) pH of Blood

1592

6377

1.58

57.80

3.4

7.41

2.38

1570

6289

(3002032) Base excess in Venous blood by calculation

4176

20035

1.33

57.59

4.9

4.0

1.90

1.81

mmol/l

0.93

3710

17607

(3043238) Trisomy 21 risk [Likelihood] in Fetus

967

10208

0.58

57.54

1.5

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

10539

56582

1.21

56.59

2.4

319.87

319.30

umol/l

0.23

9236

50733

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

8915

47068

1.23

56.48

1.4

1.3

7.99

10.52

u/ml

2.72

3517

19135

(3007461) Platelets [#/volume] in Blood

41898

256504

1.55

56.45

27.6

21.0

265.91

261.35

e9/l

38.74

41299

251857

(3024731) MCV [Entitic mean volume] in Red Blood Cells

41907

256591

1.55

56.06

27.4

20.9

90.56

90.60

1.14

41605

254433

(3035941) MCH [Entitic mass]

41906

256590

1.55

55.94

27.4

20.9

30.04

30.14

30.54

41603

254438

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2681

12038

1.41

55.70

9.5

9.9

0.65

0.66

0.25

2668

11971

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

41907

256610

1.55

55.69

28.0

21.3

40.30

40.47

0.33

41597

254354

(3026361) Erythrocytes [#/volume] in Blood

41907

256620

1.55

55.50

27.5

21.0

4.45

4.47

e12/l

14.27

41193

251335

(3005033) Fetal Nuchal fold Thickness US

929

9818

0.58

55.48

1.4

1.5

1.27

1.26

0.13

647

7174

(3010813) Leukocytes [#/volume] in Blood

41912

256666

1.55

55.33

27.6

21.0

6.70

6.67

e9/l

1.07

41198

251349

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2681

12056

1.41

55.21

1.8

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

41911

256680

1.55

54.92

27.7

21.1

132.71

133.94

g/l

68.93

41619

254579

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2746

12421

1.40

54.67

9.4

9.6

1.38

1.33

1.57

2733

12348

(3014007) Fractional oxyhemoglobin in Arterial blood

2744

12418

1.40

54.47

9.4

9.7

93.96

94.06

0.32

2736

12373

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

426

1122

2.38

54.31

3.2

2.2

179.35

145.46

umol/l

0.89

216

574

(3003181) Sodium [Moles/volume] in Urine

1043

3813

1.72

53.96

1.7

1.4

66.32

61.03

mmol/l

2.88

837

3007

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2503

11166

1.42

53.87

9.2

9.8

24.40

24.34

mmol/l

0.49

2451

10920

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

541

6619

0.50

53.54

1.2

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4859

24083

1.29

52.60

1.9

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2171

18832

0.70

50.91

4.2

3.8

22.21

21.74

0.60

861

7824

(3010838) Calcium [Moles/time] in 24 hour Urine

1120

4272

1.65

49.54

2.0

1.9

5.30

5.08

mmol/24h

1.27

1001

3874

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3437

16372

1.34

49.37

1.8

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1637

6841

1.51

49.11

2.1

2.2

446.82

487.12

ug/l

0.22

1511

6362

(3002179) Metamyelocytes/Leukocytes in Blood

3965

19321

1.31

48.50

4.1

4.3

0.67

0.70

0.26

1193

5243

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

17495

99156

1.17

48.48

4.2

3.7

0.81

0.50

estimate

0.51

4232

21624

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

860

3075

1.76

48.08

1.5

1.4

482.43

350.16

pmol/l

0.55

737

2699

(3017181) Myelocytes/Leukocytes in Blood

4133

20278

1.30

48.03

4.4

4.5

0.97

0.92

0.44

1245

5490

(3037522) Nuclear Ab [Titer] in Serum

7235

37921

1.23

48.03

1.4

477.71

562.52

titre

3.87

1540

8076

(3021440) Promyelocytes/Leukocytes in Blood

3974

19463

1.30

46.74

4.4

4.5

0.11

0.12

0.24

1086

4694

(3020630) Protein [Mass/volume] in Serum or Plasma

3347

16018

1.33

46.44

2.8

2.5

66.27

66.67

g/l

2.27

3042

14686

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1606

6789

1.49

45.58

1.4

290.14

286.41

ug/g

0.27

885

3802

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

605

1969

1.93

45.50

1.5

1.3

4.82

5.46

umol/l

3.51

535

1774

(3048689) Calprotectin [Mass/mass] in Stool

7097

37333

1.22

45.13

2.3

2.5

115.77

117.41

ug/g

0.12

5586

29682

(3005719) IgG [Mass/volume] in Serum or Plasma

3861

18979

1.30

44.03

2.8

2.9

10.24

10.51

g/l

3.86

3509

17628

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7640

40585

1.21

43.86

3.7

3.6

266.63

354.91

ng/l

1.06

5204

27739

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1043

4036

1.63

43.63

1.2

1.1

—

(3025159) Blasts/Leukocytes in Blood

3998

19781

1.29

43.32

4.7

0.48

0.21

0.98

1017

4563

(3020191) Ethanol [Moles/volume] in Serum or Plasma

544

1753

1.95

42.14

1.7

1.5

1.11

1.30

promille

2.10

431

1361

(3017732) Neutrophils [#/volume] in Blood

5886

30608

1.23

41.46

3.4

3.0

4.38

4.40

e9/l

0.04

5019

27020

(3016650) Hepatitis A virus Ab [Presence] in Serum

1047

4109

1.60

41.38

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1544

6633

1.47

40.43

2.9

3.0

24.90

24.75

mmol/l

0.77

1508

6508

(3004119) Hemoglobin [Mass/volume] in Venous blood

2588

12169

1.35

40.26

4.0

3.4

128.69

128.85

g/l

0.13

2498

11860

(3011397) Hemoglobin [Presence] in Urine by Test strip

10864

59937

1.17

40.12

4.1

3.8

0.62

0.23

0.42

117

489

(40761536) Microorganisms panel - Urine sediment

3929

19595

1.28

39.79

4.4

3.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2651

12535

1.34

39.73

5.4

4.2

24.39

24.28

mmol/l

1.03

2622

12388

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

623

2143

1.83

39.65

3.9

3.1

5.52

7.08

nmol/l

0.25

590

2067

(3041096) Erythrocytes [Presence] in Urine by Automated

12951

72516

1.16

39.47

3.6

3.2

0.33

0.20

estimate

0.52

4175

21553

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2980

23764

0.77

39.28

5.2

4.6

1.57

2.49

ug/l

5.31

2632

21613

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1634

14252

0.70

39.19

3.2

2.8

0.65

0.73

ug/l

1.35

1005

8107

(3046904) Somatotropin [Units/volume] in Serum or Plasma

12.25

38.86

3.5

1.1

2.85

3.48

mu/l

0.17

(3009466) Valproate [Moles/volume] in Serum or Plasma

841

3195

1.65

37.84

6.1

5.6

368.30

373.19

umol/l

0.37

731

2836

(3023183) Ammonium ion [Moles/volume] in Plasma

1008

4012

1.58

37.60

2.7

2.8

32.87

33.69

umol/l

0.32

908

3647

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2250

10478

1.36

37.21

3.9

3.1

1.34

1.26

2.26

2237

10429

(3036180) Methadone [Presence] in Urine

9.06

37.18

4.4

2.0

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1020

4083

1.57

37.13

3.8

3.7

5.09

5.00

kpa

3.38

998

3988

(3012501) Base excess in Blood by calculation

1019

4082

1.57

36.98

3.8

3.7

2.53

2.46

mmol/l

0.32

713

2686

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1575

6915

1.44

36.80

2.9

3.6

339.69

1768.56

u/ml

2.62

1328

5920

(3027315) Oxygen [Partial pressure] in Blood

1022

4115

1.56

36.28

3.8

3.7

8.78

8.80

kpa

0.16

1000

4019

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

541

1833

1.85

36.16

1.2

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

13024

73337

1.15

35.92

3.2

2.9

0.07

0.06

0.13

271

1363

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2225

10400

1.35

35.91

3.9

3.1

0.62

0.63

1.23

2217

10366

(1616796) Gas panel - Central venous blood

1087

4452

1.54

35.78

3.8

3.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2997

14643

1.30

35.47

1.8

1.9

1.29

1.31

g/l

0.17

2781

13568

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2443

11651

1.33

34.42

7.2

6.3

24.65

24.57

mmol/l

0.45

2349

11129

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

213

504

2.64

33.99

2.0

1.5

0.21

0.26

nmol/l

0.80

169

355

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2154

10110

1.35

33.80

1.9

2.1

40.00

40.12

u/l

0.09

1933

9227

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1618

7258

1.41

33.54

4.3

4.2

24.88

24.71

mmol/l

1.58

1499

6743

(3021901) Oxygen saturation in Capillary blood

970

3938

1.55

33.24

3.1

3.0

91.05

90.80

0.59

942

3826

(3000494) Fungus identified in Specimen by Culture

5378

28323

1.21

32.72

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

997

4093

1.53

32.50

2.7

2.5

16.56

16.62

0.23

976

4002

(3045414) Leukocytes [Presence] in Urine

4413

22813

1.23

32.25

2.2

2.0

0.03

estimate

0.11

918

4812

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

947

3873

1.54

31.42

1.6

—

(3020891) Body temperature

1923

8970

1.35

31.40

4.9

4.3

36.91

36.92

°c

1.02

1895

8889

(21494755) Public health laboratory ask at order entry panel

3667

27819

0.81

31.17

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

258

3356

0.48

30.77

1.5

1.6

7.79

7.60

mmol/l

0.80

251

3223

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2289

11006

1.31

30.38

9.6

9.5

15.98

15.94

0.31

2218

10596

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1634

7470

1.38

30.28

2.7

2.8

3.52

3.56

g/l

0.45

1550

7129

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1625

7426

1.38

30.18

2.4

2.6

181.60

180.97

0.10

1543

7025

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4317

22442

1.22

29.75

1.2

119.50

148.55

u/ml

5.60

1570

8792

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

394

1288

1.92

29.45

1.6

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1261

5567

1.43

28.61

1.7

—

(3036489) Thrombin time

1967

9339

1.33

28.52

2.1

2.2

20.68

20.81

0.38

1703

8112

(3028271) Lactate [Moles/volume] in Capillary blood

762

3038

1.57

28.32

2.0

1.8

1.66

1.69

mmol/l

0.32

744

2959

(3007566) Smooth muscle Ab [Titer] in Serum

1528

6987

1.38

28.28

1.3

105.17

127.30

titre

0.76

151

674

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1700

7937

1.35

27.59

2.5

96.20

95.57

0.53

1623

7621

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

635

2447

1.63

27.16

6.6

6.4

11.65

11.73

mg/l

0.13

583

2272

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

264

3265

0.50

27.15

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

899

3756

1.50

27.07

3.1

3.5

869.40

554.79

u/ml

0.38

794

3399

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

33546

202677

1.14

26.86

21.7

16.7

13.61

13.47

76.44

33195

200092

(3045424) Erythrocytes [Presence] in Urine

2328

11411

1.29

26.72

2.2

2.0

0.09

0.15

estimate

0.21

752

3967

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

297

911

2.04

26.59

1.4

13.60

14.49

pmol/l

2.23

247

767

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

3410

17509

1.23

26.32

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

282

853

2.07

26.20

2.3

2.4

147.70

154.82

nmol/l

0.52

250

761

(3018405) Lactate [Moles/volume] in Arterial blood

1317

5953

1.39

26.14

4.1

3.8

1.31

1.37

mmol/l

1.10

1297

5841

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

508

1868

1.70

25.97

1.1

—

(3019150) Specific gravity of Urine by Refractometry

10402

58683

1.14

25.96

4.6

3.9

1.02

1.23

kg/l

2.34

6846

38055

(3028626) Oxygen [Partial pressure] in Capillary blood

1255

5633

1.40

25.96

4.4

4.1

8.64

8.67

kpa

0.28

1227

5481

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1986

9585

1.31

25.61

4.2

3.9

49.10

48.19

0.88

1945

9460

(3013139) Helicobacter pylori Ag [Presence] in Stool

3564

18435

1.22

25.61

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

2877

14563

1.25

25.27

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1517

7055

1.35

25.26

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1376

6304

1.37

25.19

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3510

18158

1.22

25.18

2.5

2.4

21.78

20.57

au/ml

0.37

345

2308

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1289

5857

1.38

24.81

1.2

1.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

412

1446

1.78

24.78

3.4

2.9

137.50

123.06

nmol/l

0.25

406

1416

(36660697) Celiac disease serology panel - Serum

4388

23234

1.20

24.74

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

688

2772

1.56

24.50

2.5

2.7

41.00

740.66

u/ml

1.30

676

2750

(3001556) Androgen free Index in Serum or Plasma

133

293

2.84

24.36

1.7

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

407

1431

1.78

24.34

6.8

6.9

21.67

56.00

ug/l

1.20

256

936

(3017143) Hepatitis C virus Ab [Presence] in Serum

6154

33578

1.17

24.29

1.7

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1789

8576

1.31

24.23

3.7

3.4

25.34

mmol/l

0.03

1726

8290

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1379

6362

1.36

24.18

1.3

1.4

513.19

498.29

mg/l

0.26

1322

6110

(3043409) Potassium [Moles/volume] in Arterial blood

1122

5018

1.41

23.72

4.4

4.0

3.79

3.83

mmol/l

2.24

1114

4972

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1505

7068

1.34

23.51

2.1

1.9

2.45

2.16

ug/l

0.25

1320

6220

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1237

5640

1.38

23.34

1.2

1.4

3.65

3.64

mmol/l

0.22

1166

5350

(3052851) Hemolysis interference index of Serum or Plasma

1325

6110

1.36

23.31

3.0

2.9

2.15

2.28

index

0.16

653

3099

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

591

2327

1.59

23.25

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3254

16860

1.22

22.91

1.3

44.72

49.83

au/ml

0.66

163

1037

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1284

5909

1.37

22.88

1.7

1.2

4.19

3.24

ug/l

1.10

1074

5475

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

207

586

2.21

22.77

1.6

0.43

0.39

ug/l

0.71

149

433

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

102

200

3.19

22.70

3.0

1.6

15.43

2.24

nmol/l

1.88

187

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

728

3025

1.51

22.58

1.2

1.3

35.53

34.01

u/l

0.08

628

2663

(3024980) IgG subclass 4 [Mass/volume] in Serum

962

4230

1.43

22.39

1.6

1.5

0.64

0.68

g/l

0.60

682

3362

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1357

6323

1.35

22.34

2.0

2.2

10.74

11.04

mg/l

0.54

1255

5964

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1217

5592

1.37

21.91

1.4

1.5

39.62

30.00

e6/l

0.28

900

4123

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3295

17202

1.21

21.46

2.5

2.3

0.35

0.39

e6/l

0.56

3128

16278

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1551

7416

1.32

21.42

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1683

8141

1.30

21.35

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1705

8267

1.30

21.25

1.9

2.1

11.19

15.91

iu/l

0.24

701

3560

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

158

3.40

21.15

1.6

1.3

10.54

15.99

pmol/l

0.70

128

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1225

5670

1.36

21.07

1.4

1.5

4064.59

1379.38

e6/l

0.42

970

4431

(3037121) Protein [Mass/volume] in Urine

1517

7253

1.32

20.96

3.1

3.4

410.71

449.36

mg/l

0.18

659

3131

(3036603) Volume of Urine

422

1573

1.68

20.65

1.7

1.6

2068.69

2010.70

0.50

414

1541

(3016038) Potassium [Moles/volume] in Urine

395

1447

1.71

20.60

1.5

1.3

34.62

33.68

mmol/l

0.32

345

1269

(37021550) Renin [Units/volume] in Plasma --upright

147

376

2.44

20.33

1.6

1.3

68.07

93.94

mu/l

0.57

116

291

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

793

3434

1.45

20.08

1.6

1.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

601

2460

1.53

20.05

5.3

4.8

84.34

104.16

u/ml

0.38

199

838

(3034770) Mitochondria Ab [Titer] in Serum

1447

6917

1.32

20.03

1.2

1.3

704.87

995.09

titre

1.23

216

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

100

210

2.97

19.98

3.5

2.8

84.11

59.88

pmol/l

0.47

181

(3024928) Oxygen saturation in Venous blood

1110

5110

1.36

19.79

4.4

3.4

62.37

62.07

0.16

1066

4949

(3049717) Cytology report of Urine Cyto stain

1144

5296

1.36

19.68

2.3

2.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1025

4671

1.38

19.46

3.9

3.8

38.03

37.60

u/ml

0.03

998

4509

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

3339

17623

1.20

19.31

2.7

2.6

70.69

70.06

ml/min/173m2

0.33

1420

7378

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1431

6872

1.31

19.18

5.1

4.7

1.43

1.39

mg/l

1.04

1303

6366

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2755

14322

1.21

18.69

1.1

9.17

8.12

u/ml

0.04

169

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2175

11048

1.24

18.45

1.3

1.04

0.93

u/ml

0.15

195

828

(40768443) Skin Pathology biopsy report

2095

10608

1.24

18.29

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1089

5068

1.35

18.14

2.3

2.2

129.48

129.67

g/l

0.09

859

3932

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1257

5975

1.32

18.14

3.4

3.3

36.38

43.70

mg/l

0.98

1071

5058

(3034860) Kappa light chains.free [Mass/volume] in Serum

1259

5988

1.32

18.10

3.4

3.3

47.89

67.91

mg/l

0.84

1076

5066

(3022806) Fractional oxyhemoglobin in Capillary blood

574

2392

1.50

17.68

1.9

1.7

89.99

90.50

1.26

564

2355

(4062490) Immunoglobulin typing, IgG

620

2627

1.48

17.62

1.5

1.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

505

2050

1.54

17.56

3.0

3.2

24.41

25.46

mu/l

0.25

477

1950

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1572

7739

1.28

17.45

2.2

7.45

7.39

g/l

0.67

1421

7056

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1569

7729

1.28

17.33

2.2

4.30

4.25

g/l

0.84

1421

7051

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1500

7354

1.28

17.21

2.2

2.86

2.90

g/l

0.63

1350

6670

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1566

7720

1.28

17.19

2.2

3.62

3.66

g/l

0.46

1418

7045

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1461

7140

1.29

17.19

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

936

4294

1.37

17.11

1.5

1.7

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

647

2782

1.46

17.08

3.9

4.3

55.24

54.86

u/ml

0.02

642

2750

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2964

15646

1.20

17.07

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1779

8913

1.26

17.06

1.8

1.53

1.48

g/l

1.25

1505

7734

(3006653) Thiamine [Moles/volume] in Blood

320

1169

1.71

16.97

1.3

136.50

133.89

nmol/l

0.48

320

1169

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2846

14977

1.20

16.95

2.4

2.2

5.82

6.67

ug/l

1.45

2375

13034

(3020717) Zinc [Moles/volume] in Serum or Plasma

412

1610

1.60

16.88

1.7

1.5

22.96

23.44

umol/l

0.12

385

1498

(3013005) Retinol [Moles/volume] in Serum or Plasma

344

1285

1.68

16.82

2.1

2.0

1.90

1.92

umol/l

0.15

318

1175

(3002079) Sodium [Moles/time] in 24 hour Urine

309

1121

1.72

16.80

1.3

155.50

149.92

mmol/24h

0.51

309

1121

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

549

2293

1.50

16.76

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

670

2912

1.44

16.73

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1125

5337

1.32

16.50

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1372

6693

1.29

16.38

2.3

0.56

0.70

g/l

1.00

1161

5779

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

679

2974

1.43

16.28

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

665

2905

1.43

16.18

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1724

8660

1.25

16.18

5.3

4.6

1.63

1.64

0.22

1636

8214

(3027135) IgG subclass 1 [Mass/volume] in Serum

620

2675

1.45

16.12

1.5

1.4

6.26

6.75

g/l

2.83

394

1991

(3024139) IgG subclass 3 [Mass/volume] in Serum

619

2670

1.45

16.11

1.5

1.4

0.37

0.40

g/l

0.62

397

1985

(3028192) IgG subclass 2 [Mass/volume] in Serum

619

2671

1.45

16.08

1.5

1.4

2.77

2.92

g/l

1.42

394

1989

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1154

5516

1.31

16.05

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

302

1105

1.71

15.96

2.2

2.1

29.93

28.40

umol/l

1.57

287

1033

(3004809) Band form neutrophils/Leukocytes in Blood

731

3259

1.41

15.89

3.5

3.2

1.44

1.52

0.26

665

2910

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

245

845

1.81

15.83

2.6

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1243

6019

1.30

15.72

2.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1580

7885

1.26

15.69

5.6

4.8

0.87

0.88

0.24

1498

7460

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2030

10415

1.23

15.69

1.6

1.7

13.90

13.69

u/ml

0.05

438

2669

(3000012) Reticulocyte production index

561

2389

1.47

15.61

2.0

2.1

0.89

0.12

351

1543

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

606

2621

1.45

15.57

1.5

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

574

2457

1.46

15.56

2.0

25.50

24.07

mg/l

0.26

207

901

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1325

10438

0.79

15.48

1.1

0.62

0.60

ratio

0.71

180

1109

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1114

5329

1.31

15.43

3.4

3.1

6.79

5.66

ratio

0.14

656

3062

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1151

5531

1.31

15.42

3.6

0.36

iu/ml

0.13

624

3025

(3025468) Yersinia sp identified in Specimen by Organism specific culture

631

2768

1.43

15.05

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

633

2782

1.43

14.95

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

631

2779

1.42

14.74

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

145

428

2.12

14.61

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

520

2212

1.47

14.59

2.6

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2710

14390

1.19

14.58

1.1

102.70

199.67

titre

2.74

404

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4576

32084

0.88

14.44

2.0

1.8

3.34

3.37

ratio

0.79

3430

23710

(3000475) Leukocytes [#/volume] in Synovial fluid

1076

5175

1.30

14.36

1.7

10424.76

11834.74

e6/l

0.59

758

3678

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1395

6947

1.26

14.14

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

177

575

1.92

13.80

2.6

1.2

5.25

5.57

nmol/l

0.36

170

546

(42529406) Shigella sp [Presence] in Stool by Culture

1403

7016

1.26

13.74

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1400

7006

1.25

13.63

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1681

8630

1.22

12.95

1.3

36.40

37.85

u/ml

0.07

495

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

457

1944

1.47

12.89

1.2

1.3

2.03

2.01

mmol/l

0.09

421

1800

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1584

8095

1.23

12.76

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1566

7994

1.23

12.75

1.4

1.3

8.64

8.76

u/ml

0.02

230

1163

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1479

11262

0.81

12.74

1.2

1.1

0.89

0.88

g/l

2.13

1474

11233

(3040151) Glucose [Moles/volume] in Capillary blood

530

2329

1.42

12.61

16.3

5.9

7.76

7.14

mmol/l

1.12

439

1932

(3006922) Hepatitis E virus Ab [Presence] in Serum

456

1954

1.46

12.42

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

357

1455

1.53

12.37

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

715

3318

1.35

12.30

3.4

0.80

0.82

nmol/l

0.91

571

2697

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

558

2487

1.40

12.28

1.2

59.68

63.07

u/l

0.61

495

2199

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3461

24450

0.87

12.14

1.7

1.6

3.49

3.47

mmol/l

0.46

2356

16110

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

768

3614

1.33

12.05

2.9

3.3

16575.94

2479.60

u/ml

0.46

192

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1808

9422

1.21

11.99

1.5

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

3474

19094

1.15

11.96

1.4

1.3

206.70

209.56

u/ml

0.03

3234

17816

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

568

2552

1.39

11.95

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1078

5322

1.27

11.82

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1560

8027

1.22

11.79

1.4

1.3

4.38

6.56

u/ml

0.72

157

748

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1599

8249

1.22

11.77

1.8

1.9

0.23

g/l

0.62

1531

7885

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

346

1417

1.53

11.76

1.1

9.00

5.06

nmol/l

0.30

239

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1325

10118

0.81

11.75

1.9

—

20.14

—

(3018133) Calcium [Moles/volume] in Urine

169

572

1.85

11.74

1.8

2.3

2.60

2.74

mmol/l

0.41

159

525

(3042111) Morphology [Interpretation] in Bone marrow Narrative

622

2848

1.37

11.68

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1330

6737

1.24

11.67

2.2

9.79

10.13

g/l

2.13

1161

6005

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1317

6669

1.24

11.60

1.3

40.13

46.09

u/ml

0.65

144

606

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1789

9344

1.20

11.59

1.5

1.6

10.95

14.33

iu/ml

0.59

254

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1635

8473

1.21

11.51

1.8

1.9

1.20

1.19

g/l

1.30

1572

8118

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

883

0.39

11.40

1.2

66.84

67.62

ug/l

0.04

883

(3023410) Appearance of Cerebral spinal fluid

579

2635

1.38

11.31

1.5

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

115

2.99

11.27

1.6

1.5

555.85

525.17

nmol/l

0.12

115

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

388

1646

1.47

11.17

2.6

2.7

—

(3008037) Lactate [Moles/volume] in Venous blood

923

4506

1.28

11.10

3.1

3.0

1.53

1.48

mmol/l

0.60

893

4406

(3003129) Base excess in Capillary blood by calculation

481

2128

1.41

11.10

2.0

2.2

0.75

0.76

mmol/l

0.01

451

2027

(4146454) Self-monitoring of blood glucose

425

1839

1.45

11.06

2.7

2.8

—

(3037756) Immunofixation for Serum or Plasma

759

3618

1.31

10.93

1.7

—

(3014271) Vancomycin [Susceptibility]

205

752

1.70

10.92

2.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

246

950

1.62

10.79

1.6

1.3

132.65

176.21

pmol/l

2.77

246

950

(4024509) Urine culture

2050

10923

1.18

10.63

2.1

1.9

—

(3012565) Volume of 24 hour Urine

258

1013

1.59

10.59

2.1

1963.79

2005.64

0.21

236

932

(40768800) Prostate Pathology biopsy report

104

1265

0.51

10.52

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

376

1606

1.46

10.50

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

470

2095

1.40

10.43

3.4

3.3

56.56

56.75

0.06

414

1787

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1099

5523

1.25

10.41

2.3

2.2

0.00

g/l

1.69

956

4842

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

488

2195

1.39

10.28

1.2

116.52

114.34

pmol/l

0.40

488

2195

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

782

3776

1.30

10.27

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1144

5787

1.24

10.22

2.3

2.2

0.00

0.02

g/l

2.87

1018

5229

(3010015) Selenium [Moles/volume] in Serum or Plasma

103

308

2.09

10.21

2.2

2.0

1.27

1.30

umol/l

0.39

228

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

419

1839

1.43

10.15

2.3

1.9

23.67

25.71

ug/l

0.36

410

1807

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

948

4699

1.26

10.13

5.3

5.9

822.72

1142.14

iu/ml

0.31

102

669

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

646

3046

1.33

10.08

1.5

1.4

—

(40768441) Liver Pathology biopsy report

385

1666

1.45

10.07

1.3

1.4

—

(3045142) Bone marrow Pathology biopsy report

452

2015

1.40

10.04

1.4

1.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

2151

11588

1.17

9.75

1.9

7.68

7.20

iu/ml

0.27

484

2773

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

134

449

1.86

9.70

1.2

344.64

359.15

pmol/l

0.11

343

(3023199) Leukocytes [#/volume] in Pleural fluid

411

1816

1.42

9.63

1.4

2292.21

3952.31

e6/l

1.39

285

1257

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1203

6159

1.22

9.62

1.6

1.5

19.89

13.81

iu/ml

0.58

153

(3047181) Lactate [Moles/volume] in Blood

1178

6018

1.23

9.62

6.1

5.1

1.29

1.27

mmol/l

0.45

1052

5336

(3001186) Copper [Moles/volume] in Serum or Plasma

188

699

1.68

9.61

1.5

1.4

16.99

17.22

umol/l

0.24

161

600

(3022621) pH of Urine by Test strip

3597

20097

1.13

9.59

2.7

2.6

6.13

6.14

0.23

2276

12950

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

819

4016

1.28

9.58

1.4

—

(3000330) Specific gravity of Urine by Test strip

2039

10959

1.17

9.53

3.6

3.2

1.02

ratio

0.70

1810

9720

(3010370) Gastrin [Moles/volume] in Serum or Plasma

111

351

1.98

9.52

2.4

1.7

48.61

53.09

pmol/l

0.15

301

(3003434) Protein [Mass/volume] in Pleural fluid

446

2009

1.39

9.37

1.4

34.59

32.87

g/l

1.92

411

1828

(3004451) EKG impression Narrative

246

986

1.56

9.33

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

843

4167

1.27

9.26

2.5

2.4

0.88

0.86

nmol/l

0.53

707

3576

(3013336) Amino acids [Identifier] in Serum or Plasma

3.05

9.19

4.0

2.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

377

1655

1.42

9.18

1.9

2.4

102.13

99.39

0.86

349

1530

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1276

6609

1.21

9.11

1.3

4.15

5.56

u/ml

0.30

445

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1020

5169

1.24

9.02

2.4

2.2

0.00

g/l

-0.00

953

4833

(3000093) Morphology [Interpretation] in Blood Narrative

418

1885

1.39

8.76

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

863

4309

1.25

8.73

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

863

4309

1.25

8.73

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9429

62349

0.93

8.72

2.2

2.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

282

1183

1.49

8.71

1.3

64.30

66.05

0.10

148

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

330

1429

1.44

8.68

1.3

1.5

5.99

5.50

u/l

0.52

286

1208

(3027923) C peptide [Moles/volume] in Serum or Plasma

273

1139

1.50

8.66

1.6

1.8

1.28

1.31

nmol/l

0.16

195

892

(3029396) Erythrocyte agglutination [Presence] in Blood

115

1276

0.56

8.63

3.0

3.2

—

(21494815) CD4 cells/Lymphocytes in Specimen

445

2033

1.37

8.62

2.3

39.93

41.04

0.84

434

2000

(3028308) Erythrocytes [#/volume] in Pleural fluid

363

1605

1.41

8.54

1.4

61910.58

42066.71

e6/l

0.51

194

873

(1761482) Bacteria [#/volume] in Urine by Culture

896

4509

1.24

8.48

4.6

4.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

978

4973

1.23

8.41

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1580

8410

1.18

8.36

1.5

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1272

6644

1.20

8.35

1.3

24.92

13.62

u/ml

0.40

(3038515) Glucose [Moles/volume] in Venous blood

748

3696

1.27

8.30

3.3

3.1

7.35

mmol/l

0.01

724

3616

(3039000) Anion gap in Blood by calculation

793

3947

1.26

8.27

7.6

6.2

11.23

11.19

mmol/l

0.12

719

3550

(3018572) Chloride [Moles/volume] in Blood

793

3948

1.26

8.26

7.6

6.2

105.24

105.16

mmol/l

0.17

719

3552

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2114

11524

1.15

8.22

2.0

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

143

519

1.72

8.06

1.3

37.70

39.41

g/l

0.71

263

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

827

4157

1.25

7.94

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

164

2.32

7.88

3.7

2.8

161.50

85.78

pmol/l

0.27

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

325

1433

1.42

7.81

1.7

1.8

134.02

136.69

0.27

307

1362

(3045788) Cell count panel - Pleural fluid

336

1491

1.41

7.79

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

6475

43266

0.92

7.72

2.4

2.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

781

3917

1.25

7.66

1.2

1.3

295.61

314.15

titre

0.08

323

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

280

1207

1.45

7.61

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

162

620

1.63

7.54

4.4

3.2

5.12

4.92

kpa

1.53

162

620

(40768806) Pleura Pathology biopsy report

338

1511

1.40

7.53

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

324

1439

1.41

7.50

1.3

1.2

22.54

23.98

u/l

0.20

274

1212

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

162

621

1.63

7.49

4.4

3.2

10.47

10.67

kpa

0.30

162

621

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

110

378

1.82

7.48

2.5

2.7

19.44

36.85

mg/l

1.57

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

303

1.92

7.44

2.1

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

745

5747

0.81

7.43

2.1

2.3

6.25

6.09

umol/l

0.09

556

4211

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

330

1473

1.40

7.43

1.3

1.2

82.88

89.76

u/l

0.71

286

1266

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

787

3966

1.24

7.42

1.2

1.3

100.00

137.28

titre

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

467

2203

1.33

7.41

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

1338

1.42

7.41

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

367

1671

1.37

7.35

1.1

—

0.22

—

(4094501) Cardiovascular stress test using bicycle ergometer

1089

5684

1.20

7.27

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

256

1100

1.45

7.12

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2651

14813

1.12

7.09

2.8

2.9

165.85

170.53

ng/l

0.21

2387

13453

(40757494) Bilirubin.total [Moles/volume] in Blood

221

923

1.50

7.08

2.1

2.4

27.10

34.37

umol/l

0.30

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

554

1.65

7.05

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

423

1985

1.33

6.99

1.7

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

191

778

1.53

6.89

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

562

2750

1.28

6.84

1.1

112.32

77.93

au/ml

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

402

1879

1.34

6.84

1.3

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

243

1043

1.46

6.82

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

411

1929

1.33

6.80

1.1

300.36

446.31

mg/l

0.48

374

1764

(3026389) Candida sp identified in Specimen by Organism specific culture

828

4237

1.22

6.80

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

405

1897

1.33

6.80

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

452

2154

1.31

6.73

2.5

2.4

1.16

1.23

g/24h

0.21

249

1227

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

2.98

6.68

1.3

1.1

436.30

353.23

pmol/l

0.19

(3023487) Leukocytes [#/volume] in Peritoneal fluid

155

606

1.60

6.68

1.8

2.0

4319.97

2245.88

e6/l

0.24

393

(3028433) Virus identified in Specimen by Culture

170

680

1.56

6.66

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8071

53217

0.93

6.63

1.8

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

501

2428

1.29

6.60

1.6

51.01

52.79

0.42

313

1503

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3007

16995

1.11

6.57

2.4

2.3

5794.67

6248.22

u/l

0.32

1015

7009

(3010144) Erythrocytes [#/volume] in Synovial fluid

397

1868

1.33

6.48

1.5

89041.92

98023.37

e6/l

0.11

247

1238

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

497

3948

0.78

6.48

1.3

1.4

7.24

6.84

mmol/l

2.49

445

3556

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

298

1341

1.39

6.47

1.3

—

(3017509) Phencyclidine [Presence] in Urine

332

1.81

6.46

2.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

227

974

1.46

6.41

1.1

99.54

94.39

0.98

439

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

2.59

6.37

1.7

15.22

18.54

0.22

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

1157

1.42

6.35

1.5

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

755

3857

1.22

6.34

1.2

8.35

18.31

u/ml

1.67

188

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

349

1.77

6.28

2.0

1.9

—

(4034850) Laboratory test

1290

6931

1.17

6.19

9.0

9.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

293

1326

1.38

6.17

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

234

1018

1.44

6.17

1.1

1.2

114.35

111.79

0.44

210

923

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

220

946

1.45

6.16

2.0

2.2

66.19

64.92

ug/l

0.08

212

927

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

337

1560

1.35

6.16

1.1

1.08

1.09

u/l

0.10

141

608

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

165

669

1.54

6.13

1.7

2.0

40.63

40.42

g/l

0.17

165

669

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

304

1386

1.37

6.13

1.6

1.5

6.91

6.66

u/l

0.11

250

1109

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5951

39560

0.93

6.11

2.3

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

237

2071

0.71

6.08

1.6

1.5

281.02

1117.91

pmol/l

1.01

201

(3044007) Cell count panel - Peritoneal fluid

132

510

1.62

6.02

1.8

1.9

—

(3023419) Bacteria identified in Sputum by Culture

490

2402

1.28

5.95

2.7

2.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

353

1660

1.33

5.84

1.6

1.5

8.65

7.41

ug/l

0.43

319

1509

(3036782) Glucose [Moles/volume] in Pleural fluid

335

1564

1.34

5.82

1.2

1.3

6.32

mmol/l

0.01

308

1470

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

796

4127

1.21

5.80

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

288

1316

1.37

5.76

1.2

1.1

76.63

80.71

u/l

0.33

265

1175

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

418

2024

1.29

5.62

1.5

1.4

1.61

1.46

nmol/l

1.58

367

1837

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

286

1311

1.36

5.62

1.2

1.1

25.02

20.58

u/l

0.44

262

1175

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

133

525

1.58

5.59

1.3

1.2

11.59

10.96

pmol/l

0.05

187

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

226

998

1.41

5.54

1.1

94.34

93.91

0.08

447

(3044242) Glucose [Moles/volume] in Arterial blood

218

957

1.42

5.53

2.1

2.0

7.49

7.97

mmol/l

0.87

218

957

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1849

10272

1.13

5.51

1.7

3.90

4.14

mg/l

0.46

1431

7527

(3042301) Urate [Moles/volume] in Synovial fluid

4.08

5.51

1.0

363.00

314.04

umol/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

223

984

1.42

5.50

1.2

110.07

110.43

0.07

210

879

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

346

1.71

5.45

1.6

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

314

1469

1.34

5.42

2.3

2.7

1117.98

854.82

u/ml

0.63

309

1455

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

339

1605

1.32

5.39

1.3

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

235

1051

1.40

5.38

1.3

1.2

0.31

0.30

g/l

1.15

195

828

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

288

1333

1.35

5.34

1.3

501.36

402.71

u/l

0.47

271

1268

(3011412) CD3 cells [#/volume] in Blood

473

2343

1.26

5.33

2.4

2.5

1295.31

1304.61

e6/l

0.06

404

2014

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

527

2646

1.25

5.28

1.2

32.26

47.09

u/ml

0.77

141

(3004616) Nuclear Ab [Presence] in Serum

642

3293

1.22

5.27

1.4

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

299

1.75

5.23

2.4

3.0

728.69

1970.72

u/l

1.22

276

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

276

1276

1.35

5.18

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

210

928

1.41

5.16

1.3

1.4

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

101

2.35

5.16

2.2

1.8

186.88

192.86

ng/l

0.21

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

435

2143

1.27

5.14

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

210

929

1.41

5.14

1.3

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

430

0.43

5.11

3.1

3.3

31.73

45.42

3.02

430

(3006270) Folate [Moles/volume] in Blood

359

1728

1.30

5.10

1.2

1.1

381.88

384.07

nmol/l

0.07

315

1509

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

429

0.44

5.08

6.2

6.6

10.47

8.56

0.91

429

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

247

1.82

5.07

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

467

2331

1.25

4.96

1.1

1.2

35.41

40.03

mg/l

1.50

383

1965

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

364

1764

1.29

4.93

4.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

327

1563

1.31

4.91

1.7

1.8

3.50

3.54

mg/l

0.05

309

1508

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

225

1017

1.38

4.88

1.8

141.26

152.72

1.38

207

961

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

324

1548

1.31

4.88

2.4

2.6

0.73

0.77

e9/l

0.44

308

1492

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

296

1398

1.32

4.84

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

427

2116

1.26

4.84

3.4

3.0

10.73

10.61

mmol/l

0.24

419

2091

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

258

1195

1.35

4.82

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

248

1142

1.36

4.81

1.3

1.4

12.56

12.51

u/l

0.03

239

1108

(3033923) Metanephrine [Moles/time] in 24 hour Urine

114

452

1.57

4.78

1.2

1.1

0.59

0.66

umol/24h

0.71

230

(3032057) Clostridioides difficile [Presence] in Stool

101

389

1.62

4.76

1.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

119

477

1.56

4.76

1.6

1.8

36.56

33.44

u/l

0.08

106

434

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

377

1845

1.28

4.74

2.3

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

122

2.15

4.70

1.9

1.7

65.10

56.06

0.80

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

249

1152

1.35

4.69

1.0

1.1

94.97

94.76

0.04

197

913

(3022229) Phosphate [Moles/volume] in Urine

204

1.87

4.68

1.9

2.8

21.16

19.57

mmol/l

0.23

181

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.83

4.67

2.9

1.9

1345.33

1470.75

umol/l

—

(3017569) Oxygen content in Arterial blood

207

931

1.39

4.65

2.1

2.2

15.75

15.99

0.48

207

931

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

196

1.88

4.62

1.3

1.1

58.94

40.37

mg/l

1.57

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

351

0.41

4.62

1.0

1.19

1.18

mom

0.04

351

(1175426) CD3 cells/Lymphocytes in Blood

393

1941

1.27

4.61

2.2

73.75

73.62

0.05

381

1880

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

380

1870

1.27

4.59

2.1

2.2

13.22

13.76

0.58

374

1828

(3039162) Centromere protein B Ab [Units/volume] in Serum

694

3639

1.19

4.58

1.3

49.46

58.58

u/ml

0.44

222

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

532

1.51

4.56

1.7

1.8

27040.02

8712.03

e6/l

0.78

257

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

633

3295

1.20

4.53

1.1

1.49

1.48

g/l

0.37

578

3029

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

257

1203

1.33

4.51

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

257

1.75

4.50

1.5

106.66

116.55

ug/l

0.28

223

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

720

3795

1.19

4.49

1.1

76.88

3347.78

iu/ml

0.65

166

829

(4195642) Thrombophilia screening test

749

3967

1.18

4.42

1.2

—

(3010503) CD19 cells [#/volume] in Blood

273

1297

1.31

4.34

2.6

202.22

291.81

e6/l

0.55

263

1266

(3008898) HLA-B27 [Presence]

1928

10898

1.11

4.31

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

106

425

1.56

4.28

1.0

75.85

78.32

ug/l

0.26

337

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.51

4.27

1.2

1.27

1.26

u/field

0.02

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

557

1.48

4.22

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

141

603

1.46

4.22

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

448

2271

1.23

4.22

1.1

238.32

235.68

mg/l

0.08

392

2010

(21494434) Karyotype in Bone marrow

323

1578

1.28

4.18

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

253

1198

1.32

4.14

1.4

1.2

275.72

287.75

u/l

0.09

233

1122

(3035320) C reactive protein [Mass/volume] in Body fluid

380

1896

1.25

4.14

2.9

2.6

23.39

26.48

mg/l

0.90

260

1332

(3016228) CD19 cells/cells in Blood

186

842

1.38

4.08

2.1

8.74

8.60

0.05

180

823

(3035947) Staphylolysin Ab [Units/volume] in Serum

220

1023

1.34

4.08

1.2

1.1

3.92

3.52

iu/ml

0.22

(3009015) Lactate [Moles/volume] in Synovial fluid

187

1.84

4.06

1.2

5.66

5.80

mmol/l

0.07

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

367

1.58

4.04

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

882

6325

0.87

4.04

1.1

1.62

2.05

u/ml

0.81

412

3267

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

148

647

1.43

3.97

2.1

2.0

1.62

1.90

ratio

1.62

142

625

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

342

1695

1.26

3.96

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

342

1695

1.26

3.96

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

342

1695

1.26

3.96

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

217

1012

1.34

3.96

2.6

2.5

52.92

50.14

umol/l

0.56

180

903

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1408

7863

1.12

3.96

1.1

3.37

5.66

eliau/ml

2.14

174

1084

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.61

3.92

1.3

1.0

30.64

29.24

umol/24h

0.10

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

207

1713

0.75

3.90

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

337

1672

1.26

3.88

2.2

2.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.48

3.86

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

251

1.69

3.84

1.3

1.5

19.93

15.23

nmol/l

0.76

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

219

1028

1.33

3.84

1.2

18.64

12.32

u/l

0.45

197

946

(4027681) Cerebrospinal fluid IgG ratio and IgG index

359

1797

1.25

3.83

1.3

1.2

0.60

0.65

ratio

1.07

187

1037

(3051611) Lipemic interference index of Serum or Plasma

418

2128

1.23

3.82

3.2

14.01

14.64

index

0.30

243

1229

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

436

2230

1.22

3.81

1.3

77.47

65.67

u/ml

0.28

(3027974) Hepatitis B virus e Ag [Presence] in Serum

151

1.90

3.80

1.4

1.5

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

168

758

1.38

3.79

1.3

32.35

19.25

1.08

137

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

156

1.88

3.76

1.8

1.4

13.57

17.02

pmol/l

0.76

136

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

135

587

1.44

3.76

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

743

3992

1.16

3.75

1.1

120.86

119.29

0.67

673

3629

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

137

598

1.43

3.74

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

199

926

1.34

3.71

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

737

1.38

3.65

1.8

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

173

790

1.37

3.65

4.0

4.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

794

4302

1.15

3.60

1.3

4.82

4.10

u/ml

0.63

360

2009

(3018834) Bilirubin.total [Presence] in Urine by Test strip

115

2.01

3.57

3.5

3.8

0.00

estimate

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

111

2.02

3.55

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.66

3.54

1.2

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.36

3.54

1.0

1.1

198.94

220.50

pmol/l

0.10

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

267

1.64

3.54

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

354

1788

1.24

3.52

1.4

11.45

11.51

umol/l

0.06

329

1706

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

202

1647

0.76

3.46

1.4

5.64

5.42

mmol/l

2.35

191

1560

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.86

3.45

1.3

1.4

0.57

0.78

u/field

—

(40768795) Lymph node Pathology biopsy report

438

2267

1.21

3.45

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.38

3.44

1.5

1.3

205.68

130.39

nmol/l

1.22

(3051387) C reactive protein [Mass/volume] in Capillary blood

831

4534

1.15

3.43

4.0

3.2

22.88

25.27

mg/l

1.24

578

3041

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

117

1.97

3.42

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

186

870

1.34

3.39

2.2

2.1

31.17

29.97

0.54

186

870

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

138

616

1.40

3.37

1.1

97.30

86.62

0.76

125

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1334

7508

1.11

3.33

1.2

3.74

4.25

1.35

175

1148

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

138

618

1.39

3.31

1.1

70.84

74.93

0.24

122

(44806118) Parainfluenza type 4 nucleic acid detection

543

2877

1.18

3.31

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

529

2797

1.18

3.31

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

287

1.59

3.30

1.2

1.92

1.80

mmol/l

0.25

180

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

146

661

1.38

3.29

1.1

1.2

110.62

107.06

0.70

139

618

(3023383) Lactate [Moles/volume] in Pleural fluid

412

1.48

3.29

1.3

3.41

3.26

mmol/l

0.20

381

(44790048) Parainfluenza type 2 nucleic acid detection

543

2879

1.18

3.29

1.5

—

(44813793) Dust mix specific IgE antibody measurement

415

2149

1.21

3.27

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

206

1.70

3.26

1.1

—

(44790049) Parainfluenza type 3 nucleic acid detection

542

2877

1.18

3.24

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.12

3.24

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

142

1.85

3.23

1.0

—

(3033099) Centromere Ab [Titer] in Serum

140

632

1.38

3.22

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2522

14639

1.08

3.21

1.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

728

1.36

3.20

1.8

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

728

1.36

3.20

1.8

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

204

976

1.31

3.20

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

204

976

1.31

3.20

1.3

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

339

1.53

3.20

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

542

2881

1.18

3.20

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

184

1500

0.76

3.19

1.2

1.3

820.00

1085.95

titre

2.60

306

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.50

3.18

1.2

1.1

—

mmol/l

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

352

1800

1.22

3.17

2.5

2.7

217.51

220.94

e6/l

0.12

287

1491

(40762814) Titanium [Mass/volume] in Blood

237

1.63

3.15

2.7

2.5

2.96

4.16

ug/l

1.36

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

664

3594

1.15

3.11

1.4

1.5

22.14

14.22

u/ml

0.50

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

614

3306

1.16

3.09

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

322

1.53

3.08

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

332

1.52

3.08

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

110

480

1.43

3.08

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

125

559

1.40

3.06

1.4

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

127

1.87

3.04

1.9

2.4

549.34

382.30

umol/l

0.34

122

(3026692) Albumin [Mass/volume] in Peritoneal fluid

101

435

1.45

3.03

1.4

1.3

15.61

12.87

g/l

1.86

319

(3025577) Chromium [Mass/volume] in Blood

180

854

1.32

3.03

2.3

2.40

2.64

ug/l

0.39

150

729

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

349

1.50

3.01

2.2

2.3

7.06

7.32

mmol/l

0.26

205

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

264

1317

1.25

3.00

1.4

1.3

52.50

58.08

titre

0.11

104

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

599

3228

1.16

3.00

1.7

1.6

2480.00

2720.00

titre

0.08

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

340

1744

1.22

2.99

2.4

2.6

517.39

543.16

e6/l

0.33

261

1377

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

151

1.78

2.96

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

270

1353

1.25

2.96

1.4

1.3

517.06

555.19

titre

0.04

(3014133) Dog dander IgE Ab [Units/volume] in Serum

782

5522

0.88

2.96

1.1

3.96

4.44

u/ml

0.31

346

2788

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

404

2110

1.20

2.95

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

377

1957

1.20

2.94

1.2

1.3

71.57

50.85

u/ml

0.56

134

(3043410) Blood group antigens tested for on Red Blood Cells

128

580

1.38

2.92

1.9

1.6

—

(3047189) Immunofixation for 24 hour Urine

152

709

1.34

2.89

2.2

1.9

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

32571

205098

0.96

2.86

22.7

17.4

331.00

331.97

g/l

73.77

32415

203925

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

369

1.47

2.85

3.2

2.4

0.93

1.44

mmol/l

1.09

271

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

405

1.45

2.84

1.5

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

310

1.51

2.79

1.4

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

137

634

1.35

2.76

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

379

1984

1.19

2.73

1.2

161.82

213.24

titre

0.63

333

(3032868) Hemoglobin electrophoresis panel in Blood

232

1.59

2.73

1.5

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

246

1233

1.25

2.73

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

378

1.45

2.72

1.4

1.3

29.62

74.84

g/l

0.44

276

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

157

744

1.32

2.71

2.6

2.8

0.61

mmol/l

0.14

157

744

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

119

1.84

2.70

1.1

1.0

0.05

0.13

u/ml

0.89

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

258

1.55

2.67

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

744

5231

0.89

2.66

1.1

3.71

5.25

u/ml

1.52

296

2392

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

661

4681

0.88

2.66

1.1

0.15

0.38

u/ml

1.91

187

1443

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

377

1979

1.19

2.65

1.2

234.29

225.00

titre

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

319

1.49

2.65

1.1

1.4

43.53

60.22

ng/l

0.64

185

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

193

1522

0.79

2.64

1.6

1.8

1.83

2.86

u/ml

0.80

412

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

243

1222

1.24

2.63

1.0

476.00

332.73

ng/l

0.51

188

897

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

151

716

1.32

2.61

1.3

123.15

120.46

nmol/l

0.08

112

514

(3008116) Ketones [Moles/volume] in Urine by Test strip

108

486

1.39

2.61

1.4

0.19

0.40

mmol/l

1.23

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1097

7539

0.91

2.60

1.1

2.55

2.13

u/ml

0.54

551

4034

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

107

1.87

2.60

1.1

1.20

1.22

u/field

0.04

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

300

1.50

2.60

1.2

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.11

2.59

1.5

1.7

342.94

226.10

nmol/l

0.31

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

158

1.70

2.59

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

463

2479

1.17

2.58

1.2

—

(3051651) Icteric interference index of Serum or Plasma

249

1259

1.24

2.57

3.4

0.75

0.84

index

0.90

243

1228

(3028717) Thiamine [Mass/volume] in Blood

342

1.46

2.56

1.3

1.2

60.11

63.11

ug/l

0.69

342

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

243

1227

1.24

2.55

1.0

791.72

755.95

ng/l

0.64

183

868

(3038177) Helicobacter pylori Ab [Presence] in Serum

847

4729

1.12

2.54

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

181

884

1.28

2.52

2.3

3.29

3.95

ug/l

0.69

166

821

(3017817) Protein [Mass] in Urine collected for unspecified duration

315

1636

1.20

2.51

2.5

2.7

942.74

1048.56

0.47

310

1625

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

772

4293

1.12

2.49

1.1

3.07

2.90

eliau/ml

0.14

355

2110

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

470

2528

1.16

2.48

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

243

1232

1.23

2.47

1.0

39.34

41.54

ng/l

0.35

187

885

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

612

4326

0.88

2.43

1.2

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

1.95

2.43

1.5

1.6

168.15

250.66

nmol/l

0.61

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

295

1.48

2.42

1.7

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

175

1377

0.79

2.39

1.6

1.5

0.49

0.51

e9/l

0.52

175

1377

(3008401) Mugwort IgE Ab [Units/volume] in Serum

917

6323

0.90

2.36

1.1

1.19

1.02

u/ml

0.39

372

2846

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

102

1.84

2.35

1.1

1.0

0.02

0.08

u/ml

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.88

2.35

1.9

2.1

262.07

243.90

ug/l

0.19

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

243

1240

1.22

2.34

2.7

2.8

43.55

41.68

0.85

128

713

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

331

1742

1.19

2.31

1.1

1.2

1.06

ratio

0.45

274

1451

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

248

1.51

2.29

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

960

6589

0.91

2.27

1.1

3.67

5.40

u/ml

3.74

471

3562

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

932

5272

1.11

2.24

1.6

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

685

1.29

2.22

1.7

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

481

3428

0.87

2.20

2.5

27.76

27.30

iu/ml

0.03

269

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

785

1.27

2.20

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

157

769

1.27

2.19

1.6

1.9

2222.25

35176.18

u/ml

1.44

111

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

110

513

1.34

2.19

1.9

2.0

2.41

3.69

ug/l

0.60

340

(37208534) Antinuclear antibody arbitrary concentration in serum

191

958

1.24

2.18

1.1

—

(3024263) Appearance of Synovial fluid

195

981

1.24

2.17

1.8

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.97

2.16

1.0

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

2.34

2.15

1.1

1.2

82.53

23.84

mu/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2040

11946

1.07

2.14

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.05

2.13

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.97

2.12

1.1

24.99

28.44

nmol/24h

—

(3006598) pH of Arterial cord blood

185

0.47

2.12

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

114

538

1.32

2.11

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

167

830

1.26

2.09

4.1

2.9

1.48

1.24

1.10

167

830

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

205

1043

1.23

2.08

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

205

1043

1.23

2.08

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

205

1043

1.23

2.08

1.7

—

(4268621) Lupus anticoagulant assay

562

3106

1.13

2.07

2.3

—

(44806420) Estimation of glomerular filtration rate

589

3265

1.13

2.07

2.4

2.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

196

993

1.23

2.07

7.0

5.8

2438.15

5153.22

u/ml

0.27

152

(3006567) Chloride [Moles/time] in 24 hour Urine

2.36

2.05

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

573

1.31

2.05

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

265

1.46

2.05

1.1

—

(3002619) Bacteria identified in Specimen by Culture

124

595

1.30

2.05

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

205

1045

1.22

2.05

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

286

1.44

2.04

1.2

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

180

1.56

2.02

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

451

2462

1.14

2.02

1.2

—

(3035880) pH of Pleural fluid

151

746

1.26

2.00

1.2

1.3

7.43

0.06

530

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

710

3988

1.11

2.00

2.4

91.12

85.64

ug/min

0.11

396

2406

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

127

1.67

1.99

1.1

50.17

57.23

u/l

0.24

111

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

263

1.45

1.95

1.1

1.0

0.03

0.05

u/ml

0.78

263

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

449

2459

1.14

1.93

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

203

1.51

1.90

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

435

2382

1.14

1.89

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

411

2242

1.14

1.89

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

120

1.66

1.87

3.2

2.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

347

1874

1.16

1.84

1.6

41.44

33.95

2.65

210

1124

(3008536) Aspergillus sp Ab [Presence] in Serum

399

1.35

1.83

1.8

2.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

190

1.51

1.82

2.4

3.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

433

2381

1.14

1.78

1.2

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.13

1.78

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

785

4469

1.10

1.74

1.3

2.45

3.75

u/ml

2.07

267

1706

(3029634) Reagin Ab [Titer] in Serum by VDRL

677

3830

1.10

1.71

1.8

3.54

9.53

titre

1.09

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

104

1.68

1.71

1.1

—

(4211845) Urine protein measurement

226

1188

1.19

1.70

3.6

2.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

301

1621

1.16

1.69

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

346

1.35

1.68

1.3

1.2

543.99

228.87

ug/l

0.45

192

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

174

894

1.21

1.67

1.4

1.2

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.96

1.67

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

182

940

1.21

1.66

3.3

3.7

1122.16

2069.89

mg/l

0.35

127

691

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

288

1548

1.16

1.66

1.5

19.04

24.53

u/ml

1.31

268

(3007916) DNA double strand Ab [Titer] in Serum

299

1.38

1.65

1.3

1.4

272.86

96.72

titre

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

156

794

1.23

1.65

3.0

27.72

28.73

umol/l

0.39

123

594

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.27

1.65

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

315

1706

1.15

1.65

2.6

2.9

39.15

56.11

mg/l

0.70

218

1201

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

610

3442

1.11

1.64

1.2

1.1

0.58

1.18

1.84

176

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.90

1.63

1.0

1.1

0.01

0.11

u/ml

0.76

(3039744) RNA polymerase III Ab [Units/volume] in Serum

216

1.44

1.63

1.0

1.1

7.50

3.39

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

300

1.37

1.63

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

404

0.69

1.63

10.2

7.5

6.24

5.63

kpa

0.54

404

(3022475) Manganese [Moles/volume] in Blood

160

1.52

1.62

1.2

0.15

0.16

umol/l

0.33

160

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

3.90

1.61

2.0

9.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

392

1.32

1.61

2.3

2.7

5.49

547.28

ug/l

0.98

392

(3042010) Triglyceride [Moles/volume] in Pleural fluid

248

1.41

1.61

1.2

1.98

1.58

mmol/l

0.17

166

(3018333) Ribosomal P Ab [Presence] in Serum

420

2324

1.13

1.60

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1009

5832

1.08

1.60

1.3

28.47

48.51

u/ml

—

107

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1260

7346

1.07

1.59

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

719

4103

1.09

1.55

1.1

2.75

2.83

0.04

116

732

(3032352) Blasts [#/volume] in Cerebral spinal fluid

250

1.40

1.55

1.7

2.9

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.29

1.54

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.29

1.54

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.29

1.54

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.29

1.54

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.29

1.54

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.29

1.54

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

174

903

1.20

1.54

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

868

5860

0.92

1.53

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.82

1.53

1.0

1.1

0.67

1.14

u/field

—

(4015189) Microbial culture of sputum

417

1.30

1.53

2.3

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

272

1.38

1.52

1.7

1.3

42.54

56.10

1.26

138

(3005082) Progesterone [Moles/volume] in Serum or Plasma

360

2539

0.88

1.52

1.4

1.5

33.51

34.10

nmol/l

0.12

324

2352

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

315

1.35

1.51

1.4

1.2

1.31

1.79

iu/ml

1.58

171

(4212803) Bone marrow aspirate examination

138

1.54

1.50

1.1

—

(3013762) Body weight Measured

1.92

1.50

1.0

1.2

—

(3006462) Nitrate [Presence] in Urine

206

1089

1.18

1.50

3.7

2.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

869

5858

0.92

1.49

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

270

0.65

1.48

1.1

1.2

21.33

20.41

mmol/l

0.53

223

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

243

1304

1.16

1.47

1.2

13.24

11.57

u/ml

0.07

148

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

942

5454

1.08

1.46

1.4

15.25

21.63

u/ml

0.89

106

(3003694) ABO and Rh group [Type] in Blood

12026

76350

0.98

1.46

1.5

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

755

5111

0.92

1.45

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

201

1.43

1.44

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

208

1105

1.18

1.44

2.1

2.3

27.82

28.46

0.30

203

1065

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.81

1.44

1.1

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.99

1.43

1.9

1.2

1.69

2.06

g/l

0.54

(3013945) Hepatitis B virus e Ab [Presence] in Serum

145

1.51

1.43

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

115

1.57

1.42

2.2

2.6

0.66

ug/l

0.02

115

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

233

1251

1.16

1.42

1.1

8.04

11.07

u/ml

0.71

228

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

404

2815

0.89

1.41

1.4

8.72

7.74

mmol/l

3.85

376

2738

(3006576) Bicarbonate [Moles/volume] in Blood

109

545

1.25

1.40

5.4

6.1

24.74

25.00

mmol/l

0.26

501

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

250

1.37

1.40

12.4

10.6

4.86

5.28

mmol/l

0.70

250

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.70

1.38

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

168

880

1.19

1.38

1.2

0.22

0.38

g/l

0.70

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

315

1.33

1.38

1.1

—

(44806071) Cardiolipin IgM antibody measurement

375

1.30

1.38

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

947

5501

1.08

1.37

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

214

1145

1.17

1.37

1.4

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

179

944

1.18

1.37

2.2

2.4

0.46

0.22

e9/l

0.55

462

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

638

4333

0.92

1.34

2.7

2.5

13.28

13.12

3.35

633

4280

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

946

5503

1.07

1.33

1.3

253.83

257.05

u/ml

0.14

606

3493

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

277

0.68

1.31

5.1

7.0

10.82

10.65

0.11

277

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

1.61

1.89

mg/l

0.20

167

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

1.73

2.33

mg/l

0.42

182

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

4.60

3.92

mg/l

0.26

174

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

2.69

2.80

mg/l

0.04

193

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

1.44

0.93

mg/l

0.40

170

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

2.60

2.05

mg/l

0.26

198

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

3.11

2.60

mg/l

0.20

188

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

1.23

0.91

mg/l

0.18

182

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

264

1.35

1.31

1.6

1.69

1.62

mg/l

0.04

191

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

309

1705

1.13

1.30

2.1

2.0

2.24

3.48

u/field

0.43

174

943

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

196

1048

1.17

1.29

1.1

385.22

367.21

ng/l

0.03

280

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

529

3009

1.10

1.29

1.1

94.53

95.45

0.33

494

2828

(3028679) Herpes simplex virus Ab [Presence] in Serum

314

1736

1.13

1.28

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

385

1.28

1.5

7606.25

262950.91

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

325

1.31

1.27

5.7

5.2

44.73

34.34

ug/min

0.62

232

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

271

1.34

1.27

1.6

1.24

1.73

mg/l

0.46

185

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

155

1142

0.85

1.25

1.0

8.61

11.14

u/ml

0.83

737

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

347

1935

1.12

1.24

1.1

1.06

1.12

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

125

645

1.21

1.24

2.9

3.1

1.93

1.97

ratio

0.12

113

595

(3006245) CD3-CD19+ cells/cells in Blood

218

1180

1.15

1.23

2.4

2.6

10.99

10.07

0.48

209

1116

(3011436) Histone Ab [Units/volume] in Serum

106

538

1.23

1.1

—

22.64

u/ml

—

(3008896) Cortisol [Moles/volume] in Urine

2.84

1.23

1.4

1.0

308.40

70.82

nmol/l

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

482

1.24

1.23

1.4

62.16

62.75

0.06

404

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

203

1.38

1.23

1.2

1.3

28.63

208.55

u/l

0.66

149

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

445

0.76

1.22

11.6

7.5

5.87

5.96

kpa

0.30

406

(1617658) Protocol used for examination of sentinel lymph nodes

389

2187

1.11

1.21

1.1

1.0

—

(3004775) Volume in Urine collected for unspecified duration

230

1252

1.15

1.21

2.2

2.3

661.44

628.90

0.53

157

910

(3018851) Theophylline [Moles/volume] in Serum or Plasma

152

1.44

1.18

2.1

1.9

47.86

48.85

umol/l

0.06

152

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

335

1.29

1.17

1.5

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

177

948

1.17

29.0

29.5

114.88

122.06

ug/l

0.62

146

782

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

872

5088

1.07

1.16

1.5

146.01

147.94

au/ml

0.17

227

1402

(3013247) Albumin in CSF/Albumin in Serum or Plasma

127

662

1.20

1.15

1.1

6.21

5.88

mg/g

0.27

116

637

(3020356) Listeria sp identified in Specimen by Organism specific culture

249

1.33

1.14

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

268

0.70

1.14

1.1

1.4

5.89

7.55

mmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

185

1.38

1.13

2.2

3.2

1.52

1.34

mg/l

0.14

130

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

100

510

1.22

1.13

1.3

44.46

41.84

0.26

349

(3003157) Bacteria [#/volume] in Mother's milk

0.49

1.13

5.1

6.8

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

138

1.45

1.13

1.1

1.2

24.71

22.76

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

154

1.42

1.11

2.1

1.4

46.54

35.64

0.73

105

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

495

1.22

1.10

1.3

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

113

1.49

1.10

1.7

1.3

0.35

1.79

2.31

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

528

0.79

1.10

1.2

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

357

2461

0.90

1.09

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

279

1.30

1.08

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

124

1.46

1.07

3.1

5.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

161

1.40

1.06

1.2

1.0

—

(3017704) Immunofixation for Urine

173

934

1.16

1.06

1.5

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

128

941

0.85

1.05

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1955

11705

1.04

1.05

1.4

1.3

217.52

224.32

miu/ml

0.35

822

5837

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

135

1.43

1.05

2.2

1.4

19.33

11.43

0.69

101

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.60

1.05

6.4

7.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

399

2268

1.10

1.04

1.3

1.70

2.15

u/ml

0.40

231

1294

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1435

8538

1.05

1.02

1.6

1.87

6.12

iu/ml

0.64

250

1487

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

167

1199

0.87

1.02

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

173

1.37

1.02

1.1

23.00

24.35

u/l

0.16

104

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

145

775

1.17

1.02

2.1

2.0

60.84

98.69

ug/min

0.43

155

(3025130) Human papilloma virus identified in Specimen

1057

6239

1.06

1.02

1.8

1.9

—

(3013637) Mi-2 Ab [Presence] in Serum

117

614

1.19

1.02

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

614

1.19

1.02

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

614

1.19

1.02

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

614

1.19

1.02

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

366

1.24

1.00

1.6

1.7

206904.70

288141.59

nmol/l

0.19

295

(3016750) Collection duration of Urine

180

980

1.15

1.00

2.2

505.58

503.38

min

0.10

133

768

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.98

0.0

1.1

—

0.39

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

234

1.31

0.98

1.5

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

412

1.23

0.98

1.4

2.72

2.64

0.03

351

(3020650) Glucose [Presence] in Urine

169

918

1.15

0.97

1.8

1.6

0.05

0.04

estimate

0.23

169

918

(4133840) Spirometry

580

0.82

0.96

1.1

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

186

1.34

0.96

1.1

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.34

0.96

1.0

1.1

15.33

19.31

umol/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

322

0.76

0.95

2.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.73

0.94

1.2

1.1

2.15

2.72

0.57

(3000285) Sodium [Moles/volume] in Blood

364

1.23

0.93

1.3

1.2

138.24

138.04

mmol/l

0.14

303

(3022670) pH of Venous cord blood

0.53

0.91

1.1

—

(3000492) Spirometry study

4107

24993

1.03

0.90

1.5

—

19.73

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

500

0.81

0.90

2.2

2.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

232

1.29

0.90

1.2

1.1

1.51

1.62

umol/24h

0.49

232

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

146

1.37

0.87

1.3

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

1.56

0.87

4.0

2.5

40.07

35.41

umol/l

0.35

(3034891) Synovial lining cells/cells in Synovial fluid

185

1021

1.13

0.87

1.5

3.09

4.05

0.42

221

(3003577) Lead [Moles/volume] in Blood

180

0.69

0.84

1.3

1.4

0.18

0.21

umol/l

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

100

1.43

0.82

1.2

1.1

284.94

543.24

u/l

0.78

(3045462) Protein/Creatinine [Ratio] in Urine

376

1.21

0.82

4.4

5.7

55.17

185.01

mg/mmol

0.51

345

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.60

0.81

1.0

1.4

—

10987.14

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

405

1.20

0.81

6.7

7.0

4459.00

3527.71

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

156

1102

0.88

0.81

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

192

0.71

0.79

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

305

0.78

0.79

1.0

1.1

0.09

0.87

u/ml

3.63

181

(3049233) Organic acids panel - Urine

1.59

0.78

1.1

1.2

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.59

0.78

1.4

1.1

0.06

0.03

g/l

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

220

0.74

0.78

1.0

1.1

8.38

17.94

u/ml

1.78

179

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

163

901

1.13

0.77

1.2

1.1

1.83

6.35

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

260

1.25

0.77

1.6

1.2

0.35

0.53

iu/ml

1.19

135

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.44

0.77

10.4

8.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

177

1.30

0.77

1.1

1.3

0.66

0.39

u/ml

0.30

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.77

1.1

1.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

227

1.26

0.76

2.1

3.0

6.46

7.94

0.16

(3034426) Prothrombin time (PT)

149

820

1.13

0.76

1.2

27.97

27.95

0.02

149

820

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.70

0.76

1.0

1.1

—

(40760512) CD34 cells/cells in Bone marrow

2.08

0.74

1.2

1.9

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.63

0.73

1.2

1.5

309.83

395.61

mg/24h

0.53

(3045683) HLA typing for celiac disease panel - Blood or Tissue

319

1835

1.09

0.72

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

130

1.34

0.72

1.1

2.63

3.32

u/l

—

(40757373) Influenza virus identified in Isolate

360

1.20

0.71

1.7

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

136

1.33

0.70

1.2

1.3

113.50

96.97

ug/l

0.18

(3033942) Copper [Moles/time] in 24 hour Urine

120

1.35

0.70

1.5

1.3

1.54

0.54

umol/24h

0.61

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.44

0.68

4.0

3.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

150

0.71

0.68

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

524

1.16

0.67

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1576

10165

0.97

0.67

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

296

1998

0.92

0.67

1.0

1.1

0.65

1.00

u/ml

0.47

499

(3017400) Magnesium [Moles/volume] in Urine

1.49

0.65

1.0

1.4

2.06

3.18

mmol/l

2.09

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.53

0.64

1.6

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.53

0.64

1.4

1.1

0.20

0.02

g/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

484

2843

1.06

0.64

1.1

1.16

2.07

iu/ml

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

222

1.24

0.64

5.4

4.7

2.26

2.32

mg/l

0.07

188

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

141

983

0.89

0.63

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

104

568

1.14

0.63

1.5

1.4

39.51

52.20

2.70

482

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

481

1.15

0.63

1.2

1.3

31.91

75.77

mg/l

0.59

337

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

107

1.34

0.60

1.6

1.5

0.00

0.10

u/l

—

(3013862) HLA-DP [Type]

1.37

0.60

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

113

1.33

0.59

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.43

0.59

1.0

1.1

4390.75

5956.23

ng/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.38

0.59

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

1.51

0.58

1.1

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

485

1.14

0.58

1.1

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1556

1.08

0.58

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

110

610

1.13

0.56

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

184

1052

1.09

0.53

48.0

43.5

7.07

7.20

ug/l

0.43

169

962

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

228

1.20

0.53

1.0

1.24

1.29

u/ml

0.01

179

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

549

1.13

0.51

1.3

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

189

1.22

0.51

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

144

1.26

0.51

2.1

1.5

378.48

299.38

umol/24h

1.16

144

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

333

1.16

0.51

1.2

1.3

38.03

40.48

mg/l

0.18

285

(3046861) Legionella sp Ag [Presence] in Urine

122

1.28

0.50

1.0

1.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.63

0.50

1.0

2.98

12.96

u/ml

—

(40760409) HLA-A [Type] by High resolution

1.33

0.50

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

1.33

0.50

1.1

1.0

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

167

1.23

0.50

1.5

1.3

1.44

1.85

ml/s/173m2

0.38

111

(3026051) Granulocytes/Leukocytes in Pleural fluid

311

1.16

0.49

1.5

1.4

20.36

24.31

0.56

259

(3010937) Rubella virus Ab [Presence] in Serum

237

0.82

0.48

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

867

5219

1.04

0.47

1.1

17.19

15.10

au/ml

0.38

201

1408

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

198

1144

1.08

0.47

2.0

1.7

1.71

2.33

u/field

0.97

145

813

(46236302) HLA-C [Type] by High resolution typing

1.32

0.47

1.1

1.0

—

(40763590) HLA-DQ beta [Type]

1.32

0.47

1.1

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

1.26

0.47

1.1

1.4

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.46

0.46

1.4

1.2

64.36

63.24

0.04

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

221

0.82

0.45

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

113

1.27

0.45

3.0

5.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

113

1.27

0.45

1.0

0.05

0.11

u/ml

0.42

113

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

151

0.78

0.43

1.4

1.55

1.68

mg/l

0.26

129

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.56

0.42

1.2

1.6

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.56

0.42

1.6

1.0

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

200

1.19

0.41

1.7

2.1

181.03

168.68

ug/g

0.21

171

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4647

28614

1.01

0.41

2.2

2.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.39

0.40

1.0

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

122

0.77

0.40

1.0

0.00

0.07

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

394

1.12

0.40

1.0

1.1

0.33

1.71

u/ml

0.68

186

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

465

1.11

0.40

1.1

1.0

0.35

0.16

u/ml

0.23

282

(3041184) Isoniazid [Presence] in Urine

1.42

0.39

2.6

2.5

—

(3020491) Glucose [Moles/volume] in Blood

263

1735

0.95

0.38

1.8

1.7

6.48

6.33

mmol/l

0.38

184

1320

(3019174) dRVVT (LA screen)

243

1.16

0.38

1.1

1.2

—

(3032641) Amino acids panel - Urine

1.42

0.38

1.6

1.3

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

249

1.15

0.37

3.3

3.5

37.78

41.86

umol/l

0.71

214

(3024316) Viscosity of Plasma

1.26

0.37

1.1

1.6

1.34

1.55

mpas

1.29

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2053

13043

0.98

0.36

1.4

1.5

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.37

0.35

4.2

4.5

0.78

1.49

mg/l

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.39

0.35

1.0

1598.33

1905.56

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3860

23774

1.01

0.35

2.0

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

350

2282

0.96

0.34

1.1

17.17

17.64

u/ml

0.12

154

912

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.30

0.34

1.2

30.46

32.16

mg/24h

0.09

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.39

0.34

1.3

1.8

113.00

116.75

ug/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

163

953

1.07

0.33

1.1

61.68

9.20

u/ml

0.44

585

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

442

1.10

0.33

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

165

0.83

0.32

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

150

876

1.07

0.32

1.9

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

120

695

1.08

0.32

1.1

7.27

2.98

u/ml

0.35

608

(3044009) aPTT.lupus sensitive (LA screen)

248

1.13

0.30

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

240

1426

1.05

0.30

1.8

1.9

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.25

0.29

1.1

1.0

0.03

0.21

u/ml

0.75

(40762887) Creatinine [Moles/volume] in Blood

161

1.16

0.29

1.7

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.76

0.28

1.2

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

244

1.12

0.28

1.0

1.68

0.48

u/ml

0.35

223

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

122

0.82

0.28

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

133

1.17

0.27

1.6

1.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.22

0.27

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.68

0.27

1.2

1.0

167.40

164.15

g/l

—

(4038314) Semen analysis, post vasectomy

121

0.82

0.26

1.4

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.29

0.26

1.0

0.01

0.62

u/ml

1.24

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.29

0.26

1.0

1.1

0.11

0.20

u/ml

—

(3024471) HLA-A [Type]

105

701

0.93

0.26

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.25

0.26

1.3

4.4

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

175

1.14

0.25

1.3

1.4

73.96

72.47

0.10

149

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.27

0.25

1.2

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

127

0.83

0.25

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

389

2507

0.97

0.25

1.6

1.8

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.71

0.24

1.3

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

113

0.83

0.24

19.5

9.1

103.20

101.97

g/l

0.19

113

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

253

1.11

0.24

2.9

2.2

0.56

0.84

u/field

1.54

253

(3050794) Legionella sp Ab [Presence] in Serum

182

1.13

0.24

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

569

0.93

0.24

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

569

0.93

0.24

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

569

0.93

0.24

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

188

1.13

0.23

1.6

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.77

0.23

2.1

36.67

26.67

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

7.33

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

213

1.11

0.22

1.3

1.4

11.00

10.61

0.03

114

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.27

0.21

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

167

1090

0.96

0.21

3.6

3.7

8.99

8.74

mg/l

0.14

134

883

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

117

691

1.06

0.21

1.1

24.90

29.40

iu/ml

0.46

117

691

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

358

1.08

0.21

1.0

1.1

0.69

0.49

u/ml

0.12

167

(3036312) Salmon IgE Ab [Units/volume] in Serum

226

1.10

0.20

1.2

1.1

0.61

2.06

u/ml

1.06

154

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

232

1.10

0.20

1.1

81.95

90.90

titre

0.35

232

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

352

0.92

0.20

1.2

1.4

5.93

5.57

mmol/l

2.01

352

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.21

0.20

1.0

0.10

0.14

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

269

1.09

0.19

1.2

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

390

1.07

0.19

1.0

1.1

0.11

0.87

u/ml

1.42

187

(3002621) Streptococcal DNAse B [Units/volume] in Serum

276

1.08

0.18

1.0

1.1

449.27

277.59

u/ml

0.70

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.23

0.18

6.8

8.7

—

(3024932) HLA-DR beta [Type]

104

680

0.95

0.16

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

104

1.14

0.16

2.9

3.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

114

680

1.05

0.16

1.1

1.2

1.87

8.23

u/ml

2.32

455

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.17

0.16

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

158

1.11

0.15

1.1

9.00

10.05

u/l

0.18

158

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

389

2373

1.02

0.15

1.1

8.34

7.73

iu/ml

0.14

106

630

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

226

1370

1.03

0.14

1.2

11.42

9.35

mm/h

1.82

226

1370

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

211

0.92

0.14

1.3

1.4

11.28

8.27

u/ml

0.13

173

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.86

0.14

1.0

0.08

0.48

u/ml

—

(3042733) HLA Ab [Presence] in Serum

123

738

1.04

0.14

5.0

4.8

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.86

0.14

1.0

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

100

0.87

0.13

1.0

0.10

0.41

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

390

1.06

0.13

1.5

—

(3034614) HLA Ag [Interpretation]

0.84

0.13

1.0

1.2

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

100

1.12

0.13

1.0

1.1

0.05

0.07

u/ml

0.17

(3001019) Free T4 and TSH panel - Serum or Plasma

2618

16225

1.01

0.12

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

339

2156

0.98

0.12

1.1

9.72

4.91

u/ml

0.27

565

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

464

0.95

0.12

1.4

1.2

1.18

mmol/l

0.42

464

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.16

0.11

1.0

1.1

7.74

13.03

mg/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

278

0.94

0.11

8.3

10.5

0.38

0.47

umol/l

0.36

246

(3007542) Rye IgE Ab [Units/volume] in Serum

198

1.07

0.11

1.1

1.0

1.27

11.16

u/ml

0.45

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

152

974

0.97

0.10

2.9

2.8

123.03

144.56

au/ml

0.21

160

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

322

0.95

0.10

1.0

0.25

1.59

u/ml

2.23

222

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

120

1.09

0.09

5.3

4.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

339

0.96

0.08

1.0

1.1

0.42

6.38

u/ml

0.58

162

(40758358) Immune stain study

115

1.08

0.08

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

311

1.04

0.08

1.8

1.43

1.69

mg/l

0.70

267

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

262

1.05

0.08

1.0

1.1

0.33

0.59

u/ml

0.26

262

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.11

0.07

1.1

1.2

285.05

272.90

nmol/l

0.07

(3025018) Bordetella pertussis Ab [Titer] in Serum

367

2261

1.01

0.07

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

238

1.05

0.07

1.1

1.0

0.40

0.77

u/ml

0.35

133

(3020874) Milk IgE Ab [Units/volume] in Serum

363

2238

1.01

0.07

1.0

1.1

1.67

2.91

u/ml

0.70

131

754

(3001488) Cow milk IgE Ab [Units/volume] in Serum

0.89

0.07

1.0

—

1.02

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

178

1129

0.98

0.06

1.0

0.47

0.67

u/ml

0.48

173

1108

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

178

0.95

0.06

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

170

1078

0.98

0.06

1.6

3748.15

3310.49

titre

0.24

162

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

252

1552

1.01

0.06

1.3

1.4

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

266

0.96

0.06

1.0

1.1

3.33

8.81

u/ml

2.62

162

(3001729) Color of Synovial fluid

152

0.94

0.05

2.0

1.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

123

1.07

0.05

5.4

4.7

92577.00

365466.67

u/ml

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

125

794

0.98

0.05

1.6

1.7

169.29

141.15

au/ml

0.22

108

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

518

1.02

0.05

1.2

—

(3014891) Appearance of Pleural fluid

197

1.04

0.05

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

376

1.03

0.05

1.0

1.1

1.89

4.40

u/ml

0.79

295

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.07

0.05

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

309

0.97

0.05

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

460

0.98

0.05

1.5

1.6

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.07

0.04

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

315

1948

1.01

0.04

1.4

1.3

76.55

79.58

0.15

152

(3052592) Norovirus Ag [Presence] in Stool

396

1.02

0.04

1.6

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

112

1.06

0.04

9.4

10.8

85.40

313.19

e6/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

144

0.95

0.04

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

137

865

0.99

0.03

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

460

1.02

0.03

1.0

12.24

8.75

u/ml

0.27

460

(3033086) Enterovirus Ab [Titer] in Serum

1.07

0.02

1.1

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

381

0.98

0.02

1.0

1.1

0.46

3.88

u/ml

3.15

301

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

111

685

1.01

0.02

1.6

1.7

9.36

8.99

ug/l

0.36

111

685

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.07

0.02

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

294

1.02

0.01

4.4

5.5

7.36

8.45

mmol/l

2.39

294

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

257

1.02

0.01

1.7

1.6

—

(40758292) HTLV I+II Ab panel - Serum

435

0.99

0.01

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

264

1.02

0.00

3.2

3.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

291

0.99

0.00

6.2

7.0

72.26

68.12

0.44

216

(3014148) Varicella zoster virus Ab [Titer] in Serum

674

4208

1.00

0.00

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

128

0.97

0.00

1.1

0.03

1.40

u/ml

1.53

128

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.04

0.00

1.1

254.50

254.27

u/ml

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

170

1063

1.00

0.00

1.9

2.2

8.71

9.35

mg/l

0.78

141

889

(40763480) Human metapneumovirus Ag [Presence] in Specimen

102

0.98

0.00

1.0

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

103

1.03

0.00

2.1

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

123

1.01

0.00

9.1

5.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

166

1.01

0.00

1.0

0.47

9.64

u/ml

0.50

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

378

1.01

0.00

1.0

0.66

0.21

u/ml

0.34

225

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.03

0.00

1.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.04

0.00

1.0

7.66

3.47

u/ml

0.36

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.1

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.97

0.00

1.0

1.4

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

7.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.01

-0.00

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.94

-0.00

4.3

5.4

0.21

0.20

mmol/l

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

68.50

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_PCOS_CONSORTIUM_EXCLUSIONS – Exclusions for E4_PCOS_CONSORTIUM

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exclusions for E4_PCOS_CONSORTIUM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exclusions for E4_PCOS_CONSORTIUM (E4_PCOS_CONSORTIUM_EXCLUSIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints